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ABSTRACT 
Radiation doses are caused by the energy deposited in unit mass of matter from 
ionizing radiation. In the US, radiation doses from medical imaging increased six-fold in 
the past generation. Among medical exposures to patients, computed tomography (CT) 
composes about half of the collective doses, and interventional fluoroscopy composes 
14%. Radiation exposure to patients undergoing diagnostic radiological procedures 
causes increased lifetime carcinogenic risks, especially for pediatric patients who are 
more radiosensitive than adults. The correlation between procedural x-ray techniques and 
the radiation doses to patients, as well as the resultant image quality, is not well 
understood, and therefore the focus of the performed studies. 
High radiation dose levels can occur as an outcome of complex procedures 
requiring additional imaging, or when a patient undergoes multiple radiological 
procedures. Accumulated occupational doses, caused by the scattered radiation from the 
patient to the staff during the procedures, are also of concern. There are many factors that 
affect the patient radiation doses, such as different combinations of technical parameter 
settings and patient characteristics. Due to the complexities and time-consuming nature of 
clinical dose/exposure measurements, the Monte Carlo technique is the only realistic tool 
to investigate patient doses and occupational exposure.  
Therefore, the objective of this dissertation is to investigate the possible 
optimization methods of the irradiation technical factors in order to lower radiation doses 
to patients undergoing diagnostic radiological examinations using Monte Carlo 
algorithm-based software. Our general hypothesis is that incident x-ray photon energy 
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used in a diagnostic radiological procedure can be optimized to reduce patient doses 
without sacrificing image quality, and therefore can lower radiation-induced lifetime 
carcinogenic risks for patients. Our results will be valuable for medical physicists to 
analyze dose distributions, and for the cardiology clinicians to maximize image guidance 
capabilities while minimizing potential carcinogenic and deterministic risks to pediatric 
patients.   
Firstly, the impact of irradiation parameters on patient doses during CT scans was 
investigated and possible optimization methods were discussed.  Our results about cone 
beam CT scans showed that there were major differences in organ and effective dose as 
the x-ray tube rotates around the patient. This suggested that the use of x-ray tube current 
modulation could produce substantial reductions in organ and effective dose for body 
imaging with cone beam CT. For chest CT, our results showed that the existing x-ray 
tube current modulation schemes are expected to reduce patient effective doses in chest 
CT examinations by about 10%, with longitudinal modulation accounting for two thirds 
and angular modulation for the remaining one third. It was also shown that the choice of 
the scanned region affects organ doses in CT.  
Secondly, the radiation-induced cancer risks from body CT examinations for adult 
patients were estimated. For patients who differ from a standard sized adult, correction 
factors based on the patient weight and antero-posterior dimension are provided to adjust 
organ doses and the corresponding risks. Our results showed that at constant incident 
radiation intensity, for CT examinations that include the chest, risks in females are 
markedly higher than those for males, whereas for examinations that include the pelvis, 
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risks in males were slightly higher than those in females. In abdominal CT scans, risks 
for males and female patients are very similar. A conclusion was reached that cancer 
risks in body CT can be estimated from the examination Dose Length Product by 
accounting for sex, age, as well as patient physical characteristics. 
Thirdly, a set of innovative Monte Carlo models were developed to investigate the 
role of x-ray photon energy in determining skin dose, energy imparted, and image quality 
in pediatric interventional radiology using the MCNP5 platform. Contrast, relative noise, 
and contrast-to-noise ratio (CNR) were obtained for diagnostic imaging with and without 
the utilization of grids. Our results indicated that using Monte Carlo methods, the 
optimized x-ray tube voltage for a relatively low patient dose under the desired image 
quality could be obtained for any specific patient undergoing a certain type of diagnostic 
examination. 
Lastly, we investigated the changes in the pattern of energy deposition in patient 
phantoms following the use of iodinated contrast media using Monte Carlo models built 
on MCNP5 platform. Relative energy imparted to the volume of interest with iodine 
contrast agent, as well as to the whole patient phantom, was calculated. Changes in 
patterns of energy deposition around the contrast-filled volume were also investigated. 
Our results suggested that adding iodine can result in values of localized absorbed dose 
increasing by more than an order of magnitude, but the total energy deposition is 
generally very modest. Furthermore, our results also showed that adding iodine primarily 
changes the pattern of energy deposition in the irradiated region, rather than increasing 
the corresponding patient doses. 
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The goal of this project was to establish a better understanding of the roles of 
different technique factors in the patient doses from diagnostic radiological procedures. 
Based on these studies, the limitations of the current Monte Carlo software were analyzed 
and our own Monte Carlo model was proposed for simulations of patient doses during 
pediatric interventional radiology procedures. The ultimate goal of this study is to 
develop a comprehensive dosimetry database using Monte Carlo technique, with the 
output of patient doses, operator doses, and the corresponding radiation-induced 
carcinogenesis risks for pediatric interventional radiology procedures.  
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CHAPTER 1 GENERAL INTRODUCTION 
1.1   Introduction 
In the US, medical imaging resulted in a per capita dose of ~3 mSv in 2006, 
which corresponds to an increase of ~600% in a single generation [1]. Among medical 
exposures to patients, computed tomography (CT) composes 49% of the collective doses, 
and interventional fluoroscopy composes 14%. Radiation exposure to patients undergoing 
diagnostic radiological procedures causes increased lifetime carcinogenic risks, 
especially for pediatric patients who are more radiosensitive than adults. The correlation 
between procedural x-ray techniques and the radiation doses to patients, as well as the 
resultant image quality, is not well understood, and therefore the focus of this proposed 
study. 
As a routine procedure in medical imaging, the number of computed tomography 
(CT) examinations performed in the US increased from 3 million per year in 1980 to 72 
million in 2006 [2]. The effective dose for a specific CT scan depends on the technique 
and body region, and can range from ~2 mSv for a head CT to more than 30 mSv for a 
multiphase abdominal-pelvic CT [3]. In 2006, medical imaging was responsible for ~48% 
of the total radiation exposure to the US population, approximately half of which was 
from CT scans. Although there are reports implying that up to 30% of the ordered CT 
examinations may be unnecessary, it is generally recognized that in most circumstances 
CT has a favorable risk-to-benefit ratio when used diagnostically for symptomatic 
patients [4]. Due to the rapid increase of radiation doses caused by CT scans, the 
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radiology community is continually undertaking efforts to standardize and minimize 
radiation dose in CT (such as the Dose Index Registry), consistent with the As Low As 
Reasonable Achievable (ALARA) principle [5, 6]. Given the clinical advantage of better 
image quality, there will always exist the need to balance the benefits of lower radiation 
dose with resulting reduction in image quality [7]. However, there are few studies 
investigating dose reduction that take quantified image quality into consideration, which 
is likely due to the complexity of various parameter settings, patient characteristics, etc. 
Interventional Cardiology (IC) represents a series of procedures, such as coronary 
angiography, percutaneous transluminal coronary angioplasty, and electrophysiology 
procedures, which have become routine practice in the majority of hospitals and clinics [8, 
9]. In recent years, interventional cardiology has developed rapidly in terms of both 
equipment and techniques for accessing the most remote parts of the body [10, 11]. The 
increasing number of radiological procedures performed each year results in increasing 
medical radiation exposure [12, 13]. IC procedures are associated with high patient 
radiation entrance doses. These doses depend on the degree of difficulty in accessing the 
cardiac region of interest (fluoroscopy time), the patient-specific characteristics (age, size, 
and gender), the efficiency in the use of radiological equipment, and the cardiologist‘s 
experience, among other factors. There have been numerous reports of cases where 
patients suffered from radiation skin lesions and even necrosis after an IC procedure with 
radiation doses exceeding the threshold of deterministic effects (2-6 Gy for erythema, 3 
Gy for hair loss, 18 Gy for necrosis) [14, 15]. In addition to increased patient doses, the 
advent of IC procedures has resulted in a dramatic increase in occupational x-ray 
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exposure to interventional cardiologists and nurses, leading to an elevated risk of 
radiation injury and occupational health hazards [16-19].  
Radiation-induced carcinogenesis is a cause of increasing concern in recent years 
[20], particularly in radiosensitive populations such as pediatric patients and pregnant 
female patients [21-23]. This concern for infants and children is of particular interest 
because compared to adults, a larger fraction of the patient body is irradiated by the x-ray 
beam during IC procedures [24]. Furthermore, there is a pressing need to justify the risks 
of a radiation dose administrated to a patient undergoing an IC procedure with the 
procedural benefits [25]. The risk of carcinogenic and deterministic (e.g. skin lesions, 
cataracts) effects to both the patients and medical staff performing the procedures must 
be considered. Clinical follow-up and statistical analyses have shown that there is an 
increased risk of cataracts in IC staff, especially when radiation protection tools are not 
used properly [26-28].  
In order to study these clinical situations, the Monte Carlo method is commonly 
used. The Monte Carlo method is a well-established technique in the medical physics 
field when physical measurements and pure mathematical calculations are either too 
cumbersome or impossible [29]. It employs a class of computational algorithms that rely 
on repeated random sampling to compute results, which are often used in simulating 
physical and mathematical systems [30, 31]. Monte Carlo algorithms are used to simulate 
the absorbed dose in any material at any specific point in a geometric setting with high 
accuracy and small relative errors. However, few researchers have applied Monte Carlo 
simulations to IC because of the difficulty in the variability of the parameters 
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encountered from the nature of these complex procedures [32]. Investigating the x-ray 
technique parameters involved in IC procedures and their effects on radiation doses, 
without sacrificing diagnostic image quality, is currently the most challenging task in the 
field.  
1.2   Objective and Specific Aims 
Interventional Radiology (IR) contributes to 14% of the collective radiation dose 
from medical exposures and 7% of all radiation exposure types to the US population [8, 
33, 34]. High radiation dose level can occur as an outcome of complex procedures 
requiring additional imaging, or when a patient undergoes multiple interventional 
procedures [35]. Accumulated occupational doses, caused by the scattered radiation from 
the patient to the staff during the procedures, are also of concern. The staff of an IR 
department is among those most highly-exposed to medical radiation, receiving annual 
effective doses in the range of 5 to 10 mSv. Efforts have been made to investigate the 
radiation doses to patients undergoing interventional cardiology procedures as well as the 
staff, with most of them using dosimeter measurements and medical records [36]. 
However, there are many factors that affect the patient radiation doses, such as different 
combinations of technical parameter settings and patient characteristics. Due to the 
complexities and time-consuming nature of clinical dose/exposure measurements, the 
Monte Carlo technique is the only realistic tool to investigate patient doses and 
occupational exposure. Our results will be valuable for medical physicists to analyze dose 
distributions, and for the cardiology clinicians to maximize image guidance capabilities 
while minimizing potential carcinogenic and deterministic risks to pediatric patients.   
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The objective of this proposal is to investigate the effects of different x-ray 
techniques on patient doses during CT procedures using existing Monte Carlo software, 
and to build a Monte Carlo model to investigate the effects of incident x-ray photon 
energy on the skin dose and total energy imparted to the patient under a constant image 
quality. This will promote a better understanding and characterization of the importance 
of output photon energy on patient doses and the development of a novel strategy for 
optimizing radiation doses while maintaining image quality.  
Our general hypothesis is that incident x-ray photon energy used in a diagnostic 
radiological procedure can be optimized to reduce patient doses without sacrificing image 
quality, and therefore can lower radiation-induced lifetime carcinogenic risks for patients. 
To test this hypothesis, it is necessary to understand the effect of incident x-ray photon 
energy on the total energy imparted to a patient and to quantify the dose levels under a 
constant image quality. The specific aims of this proposal are as follows:  
Specific Aim 1: Investigate the impact of technical parameters on patient doses 
during CT examinations using available Monte Carlo software. Absorbed doses to 
patients undergoing radiographic examinations are related to the selection of x-ray 
technical parameters, such as tube voltage, tube current, scan region, and projection angle. 
Studies will be performed using PCXMC software [37], and the effect of various 
technical parameter settings will be studied under different types of CT scans for standard 
size adult patients. Aim 1 is addressed in Chapters 3 - 5, with each of the chapters mainly 
focusing on addressing the impact of one of the irradiation technical factors on patient 
doses: Chapter 3 on projection angle, Chapter 4 on tube current, and Chapter 5 on scan 
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length. The impact of x-ray tube voltage on the patient doses was also studied and 
discussed in Chapters 3 and 5.  
Specific Aim 2: Analyze the effect of patient characteristics on patient doses and 
risks, and explore the limitations of the existing software. Patient characteristics, such as 
gender and age, are also crucial factors that determine the effective dose and carcinogenic 
risks to patient undergoing the examination. In this aim, the ImPACT Dosimetry 
Calculator [38] will be used to study patient-specific doses and carcinogenic risks among 
different types of CT scans. Currently, existing software only generates limited 
information and doesn‘t permit the investigation of image quality, which is paramount for 
justifying the necessity of any diagnostic radiographic examination. We mainly 
concentrated on this aim in Chapter 6 by exploring the relationship between 
characteristics of adult patients (gender, age, and size) and the corresponding radiation 
doses as well as the resultant radiation-induced cancer risks for different types of body 
CT scans.   
Specific Aim 3: Develop a Monte Carlo model to investigate the relationship 
between incident photon energy, patient dose, and image quality for pediatric patients 
undergoing interventional cardiology procedures. In this specific aim, a Monte Carlo 
model with a water phantom will be built to generate all the physical quantities employed 
in this study using the MCNP5/MCNPX platform [39]. The radiation doses investigated 
will include skin dose at the x-ray beam entrance point, which is closely related to 
potential deterministic effects, as well as total energy imparted on the patient, which is 
directly correlated with absorbed dose by the patient. Image quality will be represented 
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by the contrast-to-noise-ratio (CNR), which is also a function of x-ray photon energy. 
The model developed will be utilized to study the variation of the patient dose as a 
function of incident photon energy under constant CNR. As a result, the optimized 
photon energy with the lowest dose will be determined without sacrificing diagnostic 
information. A simplified Monte Carlo model, which took into consideration the image 
quality and the absorbed doses, was developed in the project described in Chapter 7 to 
realize Aim 3. In addition, we built an in-house Monte Carlo model to study the radiation 
dose and energy imparted increase caused by utilization of the iodinated contrast agent 
during diagnostic radiology imaging, which was not applicable using the commercially 
available dosimetry software. These results were shown and discussed in Chapter 8.  
Specific Aim 4: Investigate the impact of patient size and grids on dose 
optimization based on the model developed in Aim 3. The absorbed dose to the patient 
varies with patient size. Under the same x-ray tube output, a larger patient will receive a 
lower dose. Grids are often utilized in examinations to improve image quality by 
reducing scattering, at the cost of increasing patient dose. In this specific aim, the Monte 
Carlo model developed in Aim 3 will be advanced to include different patient sizes and 
application of grids. The relationship between image quality, patient dose and photon 
energy (tube voltage) for each parameter combination will be analyzed. The impact of 
grids on the patient dose – image quality relationship was analyzed using the developed 
Monte Carlo models in Chapter 7. The additional studies to investigate the patient size 
using the derivative models from this project were proposed in the future work section (in 
Chapter 9).  
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 Successful completion of the proposed aims will provide characterization of the 
correlation between patient radiation doses and x-ray energy at a desired image quality. 
This proposed study represents the first step toward my long-term research objective to 
understand the mechanism of radiation dose optimization in diagnostic radiology. 
1.3   Organization of Dissertation 
The objective of this dissertation is to investigate the possible optimization 
methods of the irradiation technical factors in order to lower radiation doses to patients 
undergoing diagnostic radiological examinations using Monte Carlo algorithm-based 
software. The manuscript is organized in chapters of related studies that combine to 
achieve the overall aims of this project. In Chapter 2 we presented a comprehensive 
overview of the radiation dosimetry, radiation-induced carcinogenic risks, and the 
application of Monte Carlo Algorithm in dose calculations. The current proposed dose 
optimization techniques in CT are also introduced. In Chapter 3, we investigated how x-
ray tube projection angle affects organ and effective doses to patients undergoing a CT 
examination on a cone beam scanner. The effect of changing x-ray tube voltage and beam 
filtration on patient doses were also investigated and discussed. The results from this 
study showed that there were major differences in organ and effective dose as the x-ray 
tube rotates around the patient. These results also suggested that the use of x-ray tube 
current modulation could produce substantial reductions in organ and effective dose for 
body imaging with cone beam CT. In Chapter 4, we further investigated how patient 
effective doses vary as a function of x-ray tube projection angle, as well as patient long 
axis, and quantify how x-ray tube current modulation affects patient doses in chest CT 
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examinations. Our results showed that the current x-ray tube current modulation schemes 
are expected to reduce patient effective doses in chest CT examinations by about 10%, 
with longitudinal modulation accounting for two thirds and angular modulation for the 
remaining one third. In Chapter 5, the choice of the scanned region and its impact on the 
organ doses during CT scans were studied. We discovered that CT scans limited to direct 
irradiation of an organ result in absorbed doses that range from ~ 0.70 of that from a 
uniform whole body irradiation for small organs such as the bladder to ~ 0.85 of that 
from a uniform whole body irradiation for large organs such as the lungs. As a result of 
receiving radiation doses from CT examinations, the radiation-induced lifetime 
carcinogenic risks to a patient also increase. In Chapter 6, we calculated the cancer risks 
from the amount of radiation used to perform body CT examination. It is shown that 
cancer risks in body CT can be estimated from the examination Dose Length Product 
(DLP) by accounting for gender, age, and patient physical characteristics. These studies 
showed that for CT examinations that include the chest, risks in females are markedly 
higher than those for males, whereas for examinations that include the pelvis, risks in 
males were slightly higher than those in females; for abdominal CT scans, risks for males 
and female patients are very similar. In Chapter 7, we built a simulation model based on a 
Monte Carlo algorithm platform MCNP5, which enables investigation of the relationship 
among the incident photon energy, radiation dose and image quality in interventional 
radiology. Our results showed that under the same image quality during a procedure, 
patient doses were significantly dependent on the incident photon energy. We also looked 
into the impact of grids on the radiation doses and image quality. In Chapter 8, we 
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investigated the changes in the pattern of energy deposition in tissue-equivalent phantoms 
following the introduction of iodinated contrast media using MCNP simulations. The 
results from these studies indicated that adding iodine can result in values of localized 
absorbed dose increasing by more than an order of magnitude, but the total energy 
deposition is generally very modest. Our data also showed that adding iodine primarily 
changes the pattern of energy deposition in the irradiated region, rather than increasing 
patient doses. The most important findings and the overall conclusions are discussed and 
summarized in Chapter 9. Recommendations for future research are also given where 
appropriate. 
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CHAPTER 2   BACKGROUND 
2.1   Radiation Dosimetry 
 Radiation doses are caused by locally deposited energy from the interactions 
between x-ray photons and atoms in the medium. In this chapter, the typical types of x-
ray interactions in diagnostic radiology are introduced, as well as radiation dosimetry 
quantities and radiation measurement apparatus. 
2.1.1   X-ray Interactions 
X-ray is a form of electromagnetic radiation composed by energetic photons. The 
energy of an x-ray is determined by  
hE  ,      (2.1) 
where sJ.h  3410636  (known as the Plank‘s constant),  and   is the frequency of 
the electromagnetic wave.  
During the interaction between x-ray and matter, the energy of x-ray photons is 
transferred to electrons. Because these energetic electrons lose energy by interacting with 
other electrons in adjacent atoms and produce ionizations, x-ray is categorized as indirect 
ionizing radiation. X-ray interaction with matter results in local energy deposition. There 
are mainly three types of interactions at the energy level of diagnostic x-rays [40-42]: 
coherent scatter, Compton scatter, and photoelectric effect, as depicted in Figure 2.1. 
2.1.1.1   Coherent Scatter 
Coherent scatter (Figure 2.1A), also known as Rayleigh scatter, occurs when a 
low-energy x-ray photon is scattered from an atom without any energy loss. There is no 
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exchange of energy from the x-ray to the medium. However, the scattered x-ray changes 
its trajectory relative to that of the incident x-ray, resulting in deleterious effects in 
medical imaging. Coherent scattering is more likely to happen when low-energy x-rays 
are incident on high atomic number (Z) materials. 
 
Figure 2.1  (A) coherent scatter; (B) photoelectric scatter; (C) Compton scatter. (adapted 
from [43]) 
 
2.1.1.2   Photoelectric Effect  
The photoelectric effect (PE) was discovered by Albert Einstein in 1905 [41]. It 
occurs between an incident x-ray photon and an inner-shell electron in the medium 
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(Figure 2.1B). The incident photon is completely absorbed with all of its energy 
transferred to the electron which is ejected from the atom. Assuming the incident x-ray 
energy is E0 and the inner-shell electron binding energy is EB, the kinetic energy Ek of the 
ejected photoelectron is: Bk EEE  0 . Then the vacancies left by the inner-shell 
electrons are filled by outer-shell electrons, with the excess energy emitted as 
characteristic x-rays or Auger electrons. In diagnostic imaging, PE effect is only 
important when the atomic number (Z) of the medium is high and the incident photon 
energy is just above the K edge (binding energy of the K-shell electron). 
2.1.1.3   Compton Scatter 
Compton scatter occurs between outer-shell electrons and incident x-ray 
photons (Figure 2.1C). It typically occurs when the incident x-ray photon energy 
(E0) is much higher than the binding energy of the outer-shell electron. A Compton 
interaction results in a scattered photon which travels in a different direction with 
energy (E‘) less than the incident photon, as well as a positive atomic ion with an 
outer shell electron lost. The relationship between scattering angle θ and the energies 
is described by the Klein-Nishina equation: 
  cos
'


11
1
0E
E
,      (2.2) 
where 
keV
E
cm
E
511
0
2
0
0  .     (2.3) 
Equations (2.2) and (2.3) show that the energy of the scattered x-ray photon 
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decreases when its scattering angle increases. Compton scatter accounts for most of 
the scattered radiation in diagnostic radiology. 
 
2.1.2 Radiation Dosimetry and Measurement 
2.1.2.1   Incident Radiation 
Exposure 
  Exposure is a quantity used to describe the output of an x-ray generator [41]. It is 
defined by the charge liberated by ionizing radiation per unit mass of air, with the SI unit 
of C/kg: 
MQExposure / .     (2.4) 
For many years, exposure was expressed in roentgens (1 roentgen = 2.58 x 10
-4
 C/kg). 
Exposure can be measured in medical radiation dosimetry by placing an 
ionization chamber directly in an x-ray beam. Because the use of exposure with the SI 
system is cumbersome, it is gradually being replaced by air kerma [44] in measuring x-
ray beam intensities. 
Air Kerma 
 Air kerma (Unit: Gy, 1 Gy = 1 J/kg) is defined as the kinetic energy transferred 
from the x-ray photons to electrons per unit of mass of air. It is recommended as the 
calibration quantity in medical x-ray imaging by the International Commission on 
Radiation Units and Measurements (ICRU) [45] and the International Atomic Energy 
Agency (IAEA) [46].  
In diagnostic radiology examinations, an exposure of 1 R corresponds to an air 
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kerma of 8.76 mGy [41]. The intensity of the x-ray beam is positively correlated with the 
tube current-exposure time product (mAs) and x-ray tube voltage, and negatively 
correlated with the distance from the focal spot and the filtration. Figure 2.2 shows the x-
ray beam intensity of a typical diagnostic x-ray tube as a function of tube voltage and 
beam filtration at 100 cm from the focal spot.  
 
Figure 2.2   X-ray tube air kerma per unit tube current as a function of tube voltage [44]. 
 
Kerma Area Product 
 Kerma Area Product (KAP) represents the total amount of radiation incident on 
the patient, which is obtained by multiplying the x-ray beam intensity (air kerma) by the 
corresponding beam cross-sectional area, excluding backscattering radiation. It can be 
measured using an ionization chamber mounted at the x-ray tube collimator or computed 
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from the manufactory properties of the x-ray tube and generator. With the same amount 
of radiation incident on the patient (KAP), the resultant energy absorption pattern 
depends on the physical characteristics of the patient. 
2.1.2.2   Absorbed Radiation 
Absorbed Dose 
 The absorbed dose (unit: Gy or J/kg) to a certain material depends on the material 
physical characteristics for a given x-ray beam intensity. Materials with high atomic 
numbers (Z) absorb more radiation energy than the ones with low atomic numbers. If a 
medium with mass M absorbs an energy of En, the absorbed dose to the medium (Dmedium) 
is defined as 
MED nmedium /     (2.5) 
For example, for a typical diagnostic x-ray beam with average photon energy of 50 keV, 
an air kerma of 1 mGy will result in an absorbed dose to muscle of ~1.1 mGy and an 
absorbed dose to bone of ~4 mGy [42]. 
 The most useful absorbed dose quantities in medical radiology are skin doses and 
organ doses. The skin dose in a diagnostic radiologic examination is ~50% higher than 
the value of incident air kerma [44]. Organ doses are lower than the corresponding skin 
dose and depend on the x-ray beam quality and irradiation area.  
 
Equivalent Dose 
Different types of radiation (ie. α, β, γ, and x-ray) can result in different relative 
biological effectiveness (RBE), which represents the biological harm caused by radiation 
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[41]. For example, a dose of 1 mGy deposited by α-particles has greater RBE than 1 mGy 
by x-ray photons. To account for the RBE, the equivalent dose H (unit: Sv) is defined as 
rwDH  ,     (2.6) 
where rw  is the radiation weighting factor ( 1rw  for x-rays used in diagnostic radiology) 
and D is the absorbed dose in the irradiated tissue.  
 
Effective Dose 
Effective dose is designed to normalize the dose delivered to the irradiated body 
region to that of a whole-body exposure [41], and thus make risk estimation possible. The 
effective dose (E) is defined as 
ii i
HwE  ,    (2.7) 
where iH is the equivalent dose to organ i , and iw  is the tissue weighting factor which 
represents the relative radiosensitivity of the individual organ (Table 2.1). 
 
Table 2.1   ICRP 103 tissue weighting factors (adapted from [47]). 
Tissue wi 
Bone-marrow (red), breast, colon, lung, stomach, remainder tissues 0.12 
Gonads 0.08 
Bladder, esophagus, liver, thyroid 0.04 
Bone surface, brain, salivary glands, skin 0.01 
     *ICRP: International Commission on Radiological Protection [47]. 
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The summation in Equation (2.7) is over all the organs and tissues irradiated for a 
specific examination. Effective dose is by far the best indicator of the patient radiation 
risk when doses to individual organs are below the threshold for the induction of 
deterministic effects [3, 48]. 
 
2.1.2.3   Radiation Dosimeters 
A dosimeter is a device that is capable of providing measurement of the absorbed 
dose deposited in its sensitive volume by ionizing radiation [49]. Most common 
dosimeters include film badge dosimeters, thermoluminescent dosimeters (TLDs), and 
optically stimulated luminescence (OSL) dosimeters. Other commonly used ionizing 
radiation measuring devices include ionization chambers and Geiger counters.  
 
Dosimeters 
 Film is sensitive to radiation and when developed the exposed area increases its 
optical density in response to incident radiation. Film badge dosimeters can be worn 
under protective clothing and used to measure radiation doses received by radiation 
workers [50]. However, film sensitivity depends on x-ray photon energy and the film 
dosimeter absorbs 30 keV photons best, causing limited accuracy.  
  Thermoluminescent dosimeters (TLDs) have been replacing film badges. They 
can store energy absorbed during x-ray exposure in electron traps, and the trapped 
electrons are released through a heating process as visible light [51]. Lithium fluoride 
(LiF) is the typical TLD used in diagnostic radiology because it simulates the absorption 
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of x-ray by soft tissue. The detection limit of the TLD used to monitor workers in 
radiology is ~0.2 mGy [52]. 
 An optically stimulated luminescence dosimeters (OSLDs) have a similar 
operating principle to TLDs, except that the readout is performed by stimulation by light 
instead of by heating [53]. The materials used for OSLDs are quartz, feldspars, and 
aluminum oxide. The application of OSLs in medicine, including radiotherapy, is just 
beginning but slowly increasing [54-56]. 
 
Ionization Chamber 
 Ionization chambers are accurate but not very sensitive dosimetry devices after 
calibration. They detect ionizing radiation by measuring the electron charges liberated 
when x-ray photons ionize the gas inside the chamber (Figure 2.3) [57]. The Geiger 
counter is a kind of ionization chamber with a very high voltage and provides ―counts per 
minute‖. Geiger counters are sensitive and used to detect low levels of radioactive 
contamination, but they are not accurate.  
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Figure 2.3   Schematic depicting the principle of ionization chamber [58]. 
 
2.2   Radiobiology 
Radiobiology is a branch of science concerned with the methods of interaction 
and the effects of ionizing radiation on living systems [59]. When x-rays are absorbed in 
a living material, the energy absorbed is deposited in the tissues and cells and may cause 
related damage to individual cells or tissue. The total energy involved, however, can be 
relatively small. For example, a total body dose of ~4 Gy of x-rays given to a human is 
lethal in 60 days to about half of the individuals exposed. This dose represents an 
absorption of energy of only about 67 cal, which is equivalent to the amount of energy of 
raising body temperature of 0.002 ºC when converted to heat [60]. 
2.2.1   Radiation Exposure Effects on Molecular Level 
On the molecular level, the main biological effects caused by radiation exposure 
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are DNA strand breaks and chromosomal aberrations. It is reported that DNA is the 
principal target for the biologic effects of radiation, including cell killing, mutations, and 
carcinogenesis [61]. Chromosomal aberrations are caused by double-strand DNA breaks 
when cells are irradiated with x-rays.  
2.2.1.1   DNA strand breaks 
DNA single-strand breaks (SSBs) may occur when cells are irradiated with a 
modest dose of x-rays, which can be observed using DNA denaturation. As far as cell 
killing is concerned, SSBs (Figure 2.4A) are of little biological consequence because 
they are repaired readily using the opposite strand as a template. If the repair is incorrect, 
it may result in a mutation. If the breaks are well separated when both of the DNA strands 
are broken, repair could also happen readily.  
However, when the breaks occur in both strands simultaneously or are separated 
by only a few base pairs, they may lead to a double-strand break (DSB) (Figure 2.4B). 
When double-strand breaks happen, a piece of chromatin snaps into two pieces. Double-
strand breaks are believed to be the most important lesions produced in chromosomes by 
radiation, resulting in cell killing, mutation, or carcinogenesis [61]. DSBs can be 
measured using pulsed-field gel electrophoresis (PFGE) and the single-cell 
electrophoresis (also known as ―comet assay‖).  
DNA in cells is much more resistant to damage by radiation than free DNA 
because of the physical protection as well as the molecular repair reactions from the cell 
structure. It is also reported that DNA containing actively translating genes appears to be 
more sensitive to radiation [62, 63]. For a dose of 1~2 Gy, the number of DNA lesions 
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per cell immediately after the exposure is approximately: base damage > 1000, single-
strand breaks ~ 1000, and double-strand breaks ~40 [60]. 
 
Figure 2.4   (A) DNA single-strand break; (B) DNA double-strand break [64]. 
 
2.2.1.2   Chromosomal aberrations 
When double-strand breaks are produced in the chromosomes as a consequence of 
incident x-rays, the resultant broken unpaired ends are sticky and can rejoin with other 
sticky ends (unpaired ends), causing chromosome aberrations and chromatid aberrations 
[65]. Chromosomal aberrations in peripheral lymphocytes have been widely used as 
biomarkers of radiation exposure with the lowest detectable single dose of 0.25 Gy [60]. 
The radiation dose can be estimated by comparison with in vitro cultures exposed to 
known doses and used to determine whether the suspected exposure to a person is a real 
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exposure. 
 
2.2.2   Radiation Exposure Effects on Cellular Level  
The radiation-induced damage on DNA in the cell nucleus is responsible for most 
of the radiation-induced cell death. Different types of cells have various levels of 
sensitivity to radiation [66]. In 1906, radiologist Jean Bergonie and histologist Louis 
Tribondeau put forward the Law of Bergonie and Tribondeau [67, 68] stating: 
1). Stem or immature cells are more radiosensitive than mature cells; 
2). Younger tissues and organs are more radiosensitive than older tissues and organs; 
3). The higher the metabolic cell activity, the more radiosensitive it is; 
4). The greater the proliferation and growth rate for tissues, the greater the 
radiosensitivity. 
 
Cell survival curves (an example shown in Figure 2.5) are used to describe the 
relationship between the radiation dose and the proportion of cells that survive. In general, 
a dose of 100 Gy is necessary to destroy cell function in non-proliferating systems, while 
the mean lethal dose for loss of proliferative capacity is usually less than 2 Gy [60].  
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Figure 2.5   Cell survival curve of human glioma cells irradiated with 240 kVp x-rays in 
vitro [69]. 
 
2.2.3   High-dose Effects and Low-dose Effects 
High-dose radiation exceeding the threshold dose could result in deterministic 
effects, including skin damage, cataractogenesis, sterility, and even death. The practical 
threshold dose in diagnostic radiology is 2 Gy [42]. As a quantitative description of 
irradiation effects, the half lethal dose (LD50) is defined as the uniform whole-body dose 
that would kill 50% of the population. The LD50 is 3 to 4 Gy within 60 days for young 
adults without medical intervention [42]. 
Below the threshold for induction of deterministic effects (< 2 Gy), radiation can 
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result in carcinogenesis [70, 71], which is the principal concern in diagnostic radiology. It 
is a type of stochastic effect, with the severity of the effects independent of the radiation 
dose, but the probability of the cancer induction increases with radiation dose. Radiation-
induced carcinogenesis could be expressed using levels of radiation-induced risks. 
2.2.4   Radiation-induced Risks 
The biological consequence resulting from low-dose irradiation is often 
characterized by radiation-induced carcinogenic risks, because low-dose radiation acts 
principally on early stages of tumorigenesis based on available animal data [72]. Studies 
of atomic bomb survivors, medical radiation, occupational radiation, and environmental 
radiation have been performed to estimate cancer risks [73]. Epidemiological studies of 
the Japanese survivors of the Hiroshima and Nagasaki atomic bombs demonstrated a 
linear relationship between cancer incidence and organ dose over a range extending 
between two and three orders of magnitude [74-77]. 
Major scientific bodies, including the Committee on the Biological Effects of 
Ionizing Radiation [73], International Committee on Radiological Protection [47], and the 
United Nations Scientific Committee on the Effects of Atomic Radiation [25] all assume 
that radiation risks exist at low doses for radiation protection purposes. Figure 2.6 shows 
the total cancer incidence of males and female with various ages based on data from 
BEIR VII [73]. The linear no-threshold (LNT) model is by far the most popular model 
describing the relationship between radiation exposure and cancer development in 
humans [78]. 
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Figure 2.6   Total cancer incidence risks from BEIR VII Report. 
 
2.3   RADIATION DOSES IN INTERVENTIONAL RADIOLOGY 
2.3.1   Interventional Radiology Suite 
A typical interventional radiology suite is usually composed of one or two C-arms, 
a patient support table, a group of monitors, a set of foot pedals for operating the x-ray 
tubes, and a control console for controlling the movement of the C-arms and the patient 
table. Figure 2.7 shows a typical interventional radiology suite [79]. 
Interventional radiology demands an increased awareness of the fundamental 
radiation protection principles of time, distance, and shielding. Unlike other areas in 
medicine in which ionizing radiation is used to diagnose or treat disease (e.g., therapeutic 
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radiology, nuclear medicine), x-ray use is not completely regulated at the federal level. A 
variety of recommendations have been put forward by different organizations, including 
the Occupational Safety and Health Administration (OSHA) [80], International 
Commission on Radiological Protection (ICRP) [81], and the International Commission 
on Radiation Units and Measurements (ICRU) [45]. In general, doses should always be 
kept ―as low as reasonably achievable‖ (ALARA) [82]. 
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Figure 2.7   Interventional radiology suite: (A) a biplane interventional suite [(1) floor 
mounted C-arm (plane A), (2) ceiling mounted C-arm (plane B), (3) table, (4) monitors, 
(5) foot pedals, (6) control console]; (B) the suite in use [79]. 
A 
B 
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2.3.2   Patient Doses  
As one of the departments where the highest doses of x-rays are delivered to 
patients, interventional radiology (IR) has few references about patient dose reference 
levels at present. 
2.3.2.1   Kerma Area Product  
Kerma area product (KAP, unit: Gy-cm
2
) is an indication of the input patient 
doses, and it is the recommended quantity by the International Commission on Radiation 
Units (ICRU) to measure patient doses in IR [83], which is equal to the quantity known 
as Dose Area Product (DAP) clinically. Several attempts have been made to establish the 
reference levels for KAP in IR [84-86], particularly in interventional cardiology [87-92].  
DAP is typically measured with an ionization chamber located near the collimator 
(Figure 2.8), and is independent of source-to-skin distance. However, DAP is a poor 
analogue of skin dose, as it does not take into consideration the skin area being irradiated. 
Estimation of absorbed skin dose from DAP data has a potential error of ~ 30%-40% [93].  
 
Figure 2.8   Diagram of C-arm fluoroscopic unit with DAP ionization chamber [93]. 
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For interventional cardiology, Neofotistou et al [87] proposed reference levels 
(RLs) of DAP for the two most common types of invasive cardiology procedures: 45 Gy-
cm
2
 for coronary angiography (CA) with fluoroscopy time of 7.5 min and 75 Gy-cm
2
 for 
percutaneous transluminal coronary angioplasty (PTCA) with fluoroscopy time of 17 min. 
In 2009, Vano et al performed a national survey which sampled 1391 kerma area product 
(KAP) randomly from 10 public hospitals [86]. In this study (as shown in Table 2.2), the 
proposed reference levels of KAP for different procedures were: 73 Gy-cm
2
 for lower 
limb arteriography, 80 Gy-cm
2
 for biliary drainage, 289 Gy-cm
2
 for hepatic 
chemoembolization, 236 Gy-cm
2
 for uterine embolization, etc. 
 
Table 2.2   KAP (Gy-cm
2
) values for different procedures [86]. 
 
 
2.3.2.2   Skin Dose 
Skin injury is a deterministic effect of radiation when a threshold dose is 
exceeded [93]. Radiation-induced skin damage is known as a rare complication of 
fluoroscopically guided interventional procedures [14, 94-98]. However, skin damage can 
occasionally occur as the result of the cumulative dose from multiple diagnostic 
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procedures. Tissues at risk include the skin, hair, subcutaneous fat, and muscle [99, 100].  
Generally speaking, the threshold dose for transient skin injuries is ~ 2Gy for 
erythema and ~ 3 Gy for hair loss [93]. Figure 2.9 illustrates hair loss, epilation on scalp, 
as well as skin injury on the neck of a 60-year-old woman after a 70 minutes long 
neurointerventional procedure for the treatment of an acute stroke. No dose estimates 
were available for the case. Table 2.3 lists the effects on skin and hair (of the neck, torso, 
pelvis, buttocks, or arms) as a function of input radiation dose and duration of time. 
Prompt reactions occur less than 2 weeks after irradiation [101, 102]; early reactions 
occur 2-8 weeks after [103]; midterm reactions occur 6-52 weeks after [104]; primary 
long-term reactions occur more than 40 weeks after [105].  
 
Figure 2.9   Radiation injury in a 60-year-old woman after a neurointerventional 
procedure [106]. 
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Table 2.3   Tissue reactions from single-delivered radiation dose to skin and hair [106]. 
 
A review published in 2010 [106] concluded that skin irradiated to a dose higher 
than 3-5 Gy often looks normal but reacts abnormally when irradiation is repeated. When 
the same area of skin is exposed to levels higher than a few grays, the effects of previous 
irradiation should be included when estimating the expected tissue reaction from the 
additional procedure [106]. 
2.3.2.3   Effective Dose 
 The effective dose is a descriptor that can be used to characterize radiation 
exposure to patients in interventional radiology [107]. Computation of effective dose 
requires knowledge of absorbed dose to all irradiated organs and tissues, which may be 
obtained by means of Monte Carlo computational techniques [108] or direct 
measurement in anthropomorphic phantoms [3]. Effective doses can be obtained from 
different measurement quantities, such as dose area product, or air kerma measurement 
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[109]. 
In a study performed by Brambilla M et al [110], low mean effective dose 
estimates were shown to lie in extravascular procedures (4.8 - 28.2 mSv), intermediate 
effective dose values for neurointerventional procedures (12.6 - 32.9 mSv), and higher 
effective doses for vascular procedures involving the abdomen (36.5 - 86.8 mSv). 
Calculations aiming at obtaining the DAP to effective dose conversion factor in 
abdominal and vascular interventional radiology [111] showed a result of ~ 0.15 mSv/ 
Gy-cm
2
. 
2.3.2.4   Energy imparted 
Energy imparted in a patient during an IR procedure could also be used to 
calculate the effective dose, as advanced by Huda et al [112]. Under the condition of  a 
uniform whole-body irradiation, the smaller mass results in a higher conversion factor to 
convert energy imparted to effective dose; under non-uniform exposure, the radio-
sensitivity of an irradiated region also needs to be taken into account when energy 
imparted is converted to effective dose [113, 114]. Thus, an estimate of energy imparted 
on a patient undergoing any given radiology imaging procedure can be used to compute 
the effective dose [115, 116] and then converted to patient specific radiation-induced 
carcinogenesis risks [117]. A set of effective dose to energy imparted conversion factors 
(E/ε, mSv/J) was obtained for different projection angles and patient ages (as shown in 
Figure 2.10) [112]. 
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Figure 2.10   E/ε vs patient age [112]. 
2.3.3   Operator Doses 
 In the past couple of decades, much attention has been directed to patient 
radiation doses and patient risks. Operator doses originated from the scattered radiation 
from the patient. Considering that the majority of radiation doses received by hospital 
staff using x-rays is from fluoroscopic procedures [118], the operator doses and 
corresponding risks in IR is also considerable. The doses received by the radiology staff 
mainly depend on the shielding, the distance from the x-ray tube, operation time, as well 
as the amount of incident radiation. 
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2.3.3.1   Operator protection measures 
 Radiology staff wears lead aprons equivalent to 0.25 - 0.5 mm lead to protect their 
trunks from scattered radiation from the IR procedure. Thyroid collars equivalent to 0.35-
0.5 mm lead are also utilized to protect the neck. For radiology staff wearing a lead apron 
but no thyroid collar, the effective dose more likely results from the unprotected organs 
in the head and neck. Various groups have assessed the ratio of effective doses for 
individuals with a lead apron and no thyroid collar to those with aprons and thyroid 
collars, and the mean ratio value is ~2.0 [29, 119-122].  
 Other protection measures include the drapes from the patient table and protection 
screens etc. They are used in the IR operation room according to the practice of the 
operator and arrangement of the room setting. Table 2.4 provides the degrees of 
protection effectiveness offered by different techniques and devices [118, 119, 123-127]. 
 
Table 2.4  Degrees of protection offered by different techniques/devices (adapted from 
[118]). 
 
2.3.3.2   Procedure Type and Doses 
The procedural position in which interventional cardiologists and radiologists 
stand relative to the x-ray beam has a significant effect on the doses received by the 
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operators. The farther the operator is away from the irradiated area, the lower the doses 
received by the operators are, and vice versa.  
In procedures such as coronary angiography (CA) or percutaneous coronary 
interventions (PCI) where the introduction of a catheter is via the radial artery route, the 
operator needs to stand closer to the area being irradiated, than those using the femoral 
axis route (Figure 2.11A). While in procedures such as transjugular intrahepatic 
portosystemic shunt (TIPS) with access via the internal jugular vein (IJV), operators are 
located further from the irradiated area (Figure 2.11B). 
 
 
Figure 2.11   Position of the operator‘s hands manipulating catheters during (A) 
interventional cardiology through radial and femoral access; (B) internal jugular vein 
(IJV) procedures through percutaneous and femoral access [118]. 
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 The type of IR procedure and its corresponding access method should be taken 
into account for calculating the amount of radiation received by radiology staff, and 
should also be considered as a factor to decide the position of the protective screen. 
 
2.3.3.3   Effective Dose 
 The mean effective dose calculated from monitoring data indicate that the 
effective dose per interventional cardiology procedure are between ~ 0.2 µSv and ~4.0 
µSv [128-132] with some exceptions [133]. This will result in an annual effective dose 
between ~0.1 mSv and ~2 mSv, assuming that an individual performs 500 procedures per 
year. However, these effective dose calculations assume that good protection measures 
are in place consistently. Even under similar protection measurement conditions, 
variations in calculations still exist because of the erratic use of dosimeters by some 
clinicians. For example, according to Monte Carlo simulation results [29], a dosimeter 
worn on the front or right side of the chest will record doses that are 1.5–2.5 times less 
than those on the left side facing the x-ray source. Thus, it is almost impossible to achieve 
a high degree of accuracy. 
 
2.3.3.4   Organ Dose and Extremity Dose 
 The most important organ doses and extremity doses to interventional radiology 
staff are the absorbed doses to hands, eyes and thyroid. The median and quartile for the 
data of operator dose per DAP (unit: µGy Gy
-1
cm
-2
) values, including doses to the 
operator‘s eyes, thyroid, hand, leg, and effective dose, are listed in Table 2.5. 
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Table 2.5   Distributions of data for operator dose/DAP [118]. 
 
 
As depicted above, the hand doses depend mostly on the types and access points 
of the procedure (Figure 2.12). Even during an individual procedure, when the hands of 
the interventionalist are close to the edge of the x-ray beam, the doses to his/her hands 
will be much higher than those when the hands are further from the beam, where they are 
partly shielded by the patient‘s body [124, 133-137]. 
 
 
Figure 2.12   Number of IR procedures as a function of the mean hand dose [124]. 
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The dose to the eye needs to be monitored to ensure that the dose does not 
approach the level at which lens opacities might occur [138] (Table 2.6). The most 
important factor affecting eye dose is the usage of eye shields, and other factors include 
lead glass screens, tube angulations, operator position, and beam collimation [123, 126, 
133, 139]. A rule of thumb for predicting eye dose levels for cardiac catheterization 
procedures proposed by Pratt et al is ~5 mSv per 100 procedures [139]. An operator 
undertaking more than 900 procedures would be likely to exceed three-tenths of the 
annual dose limit of 150 mSv, which is the classification level set by 1985 ionizing 
radiation regulations [140]. 
 
Table 2.6  Threshold doses for different radiation damages of eye lens [141].  
 
  
Thyroid dose is sometimes used as an indication of eye dose since it is easier to 
detect. Equation (2.8) [142] could be used to drive the estimate of eye dose from a given 
thyroid dose: 
Dose Thyroid.Dose Eye  750     (2.8) 
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2.4   Monte Carlo Applications in Diagnostic Radiology 
2.4.1   Monte Carlo Method 
The Monte Carlo (MC) method is an application of laws of probability and 
statistics to the natural sciences. The essence of the method is to use various distributions 
of random numbers, each distribution reflecting a particular process in a sequence of 
processes such as the diffusion of neutrons in various materials, to calculate samples that 
approximate the real diffusion history [143, 144]. The development of computer 
techniques made the laborious Monte Carlo approach possible and extremely useful for 
many physics problems. Over the last 50 years, Monte Carlo techniques have become 
ubiquitous in medical physics with a doubling of papers on the subject every 5 years 
between the first PMB paper in 1967 and 2000 [30]. 
Monte Carlo approaches tend to follow a particular pattern [145]: 
1). Define a domain of possible inputs;  
2). Generate inputs randomly from the domain using a certain specified probability 
distribution;  
3). Perform a deterministic computation using the inputs; 
4). Aggregate the results of the individual computations into the final result.  
 Use a simple integration problem [146] as an example to demonstrate the 
principle of Monte Carlo method: 
Evaluate 
2
1
0
1 xxgdxxgG   )(         with,)( . 
The distribution of the function g(x) is shown in Figure 2.13.  
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Figure 2.13   (A) Function g(x); (B) schematic of Monte Carlo solution. (adopted from 
[146])  
 
If mathematical approach is used to solve this problem, the solution would be: 
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 However, if the Monte Carlo method is employed to solve this problem, the 
process will be similar to a game of darts (as shown in Figure 5.1B): 
) ,( in randomly ˆ  ,ˆ choose       ,, For 101 kk yxNk  , 
hit"" a tally  1,ˆˆ  if  kk yx , 
N
G
Hits of Number
)(]curve under area[  11 . 
When the number of cases (N) is big enough, the result from Monte Carlo method 
should be the same as the mathematical method. 
 As shown above, MC methods are more intuitive than the mathematical methods, 
but they use considerably more computation power to generate the results. The core 
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algorithm of MC methods includes random number generation [147, 148], random 
sampling [149], variance reduction, etc. 
 
2.4.2   Application of Monte Carlo in Medical Physics 
2.4.2.1   Monte Carlo Software for Medical Physics 
Monte Carlo N-Particle (MCNP) is a general-purpose Monte Carlo code package 
that can be used for neutron, photon, electron, or coupled neutron/photon/electron 
transport. The MCNP system is maintained by a large group at Los Alamos National 
Laboratory [150] and has many applications outside medical physics since it was 
originally a neutron–photon transport code used for reactor calculations [151]. This code 
has a very powerful geometry package and has incorporated the electron transport part 
from the ETRAN code system. The great flexibility of this code makes it run 
considerably slower than EGSnrc[30].  
Electron Gamma Shower (EGS) code was developed by Ralph Nelson et al in 
1974 [152]. On the basis of this platform, the current EGSnrc system is developed as a 
package for Monte Carlo simulation of coupled electron-photon transport within the 
energy range of 1keV to 10 GeV. EGSnrc improved its former version of EGS4 which 
was developed at Stanford Linear Accelerator Center (SLAC) and incorporated 
improvements in the implementation of the condensed history technique for the 
simulation of charged particle transport and better low energy cross sections [153]. 
BEAMnrc, based on the EGSnrc code system, is a general purpose MC simulation 
system for modeling radiotherapy sources [154]. 
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The PENELOPE code package has a detailed treatment of cross sections for low-
energy transport and a flexible geometry package which allows simulation of an 
accelerator [155, 156]. The GEANT4 code [157] is a general purpose code developed for 
particle physics applications, which can simulate the transport of many particle types 
(neutrons, protons, etc). GEANT4 has been used for various application in radiotherapy 
physics [158, 159]. It still demonstrates some problems when electron transport is 
involved and runs slower than EGSnrc in such applications [160, 161], but overall the 
system is very powerful. 
2.4.2.2   Applications of MC software in Medical Physics 
The Monte Carlo method could be used to perform calculations for radiation 
protection and dosimetry, radiation shielding, radiography, nuclear criticality safety, 
detector design and analysis, accelerator target design, and fission and fusion reactor 
design. In the medical physics area, the applications of Monte Carlo codes have been 
employed to conduct calculations on detection systems, imaging correction, absorbed 
doses, and radiation protection in nuclear medicine, diagnostic radiology and 
radiotherapy [31]. They are also applied in treatment planning and brachytherapy in 
radiotherapy physics.  
 
2.4.3 Current Research on IR using MC Method 
The literature on patient and occupational dose levels has been reviewed in 
Chapter 4, so in this section, the focus is on the MC simulation and methodology used in 
available representative literature. 
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5.3.1 MC Method in Patient Dose Calculation 
 An early pilot research by Rannikko et al [162] in 1997 simulating patient doses 
using the MC method (ODS-60, Rados Technology, Finland) showed that the entrance 
dose to effective dose ratios of male (170 cm, 85 kg) and female (160 cm, 43 kg) 
phantoms varied between 1.5 - 2. In 2000, a study was performed by Putte et al [163] 
examing the correlation between patient skin doses and DAP values in interventional 
procedures. Standard cardiac catheterization procedures with different x-ray tube 
angulation and fluoroscopy time, kV and mA setting combinations were simulated under 
the geometry shown in Figure 2.14 using MCNP codes and mathematical phantoms 
generated by BodyBuilder (White Rock Science) [164].  
A skin layer thickness of 0.2 cm was simulated and 34,560 conversion factors 
were calculated relating DAP to skin dose for 3,456 skin regions. The results of their 
study are shown in Figure 2.15, showing the doses at the back and right side of the body 
much higher than at the front or left side, which is caused by positions of the x-ray tubes 
in the simulated biplane interventional suite [163]. 
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Figure 2.14   Monte Carlo geometry with arrows indicating TLD positions in the study 
[163]. (L: lungs; H: heart; S: spine)  
 
 
Figure 2.15   Contour plot of dose distribution (mGy) for cardiac catheterization. The 
circumference is measured counter-clockwise starting from middle of the chest. The 
horizontal line indicates position of the center of the heart [163]. 
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 Other current available research related to patient doses received in IR procedures 
include MC simulations of radiation doses to the lens of the eye [165] and to lower limbs 
[166]. 
5.3.2 MC Method in Occupational Dose Calculation 
The STUK (Radiation and Nuclear Safety Authority) group of Finland [167] 
performed a study concerning occupational radiation doses using MCNP platform in 
2007-2008 [29, 122]. The simulated setting is demonstrated in Figure 2.16. Their results 
indicated that all the doses are especially sensitive to the changes in the position of the 
radiologist. For example, a 20 cm movement of the radiologist may change the ratio of 
the dosimeter reading to effective dose by ~50%. 
 
Figure 2.16   Schematic depicting the simulated radiologist and patient: (A) top view (the 
grey square indicating the irradiation area);  (B) right-side view [122].  
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 In 2007, Bozkurt et al [32] used an image-based voxel phantom (VIP-man) [168] 
based on MCNP codes with a height of 1.76 m and a weight of 73 kg, with one patient 
and one physician standing 15 cm away from about the waist level of the patient. The 
physician was simulated wearing a lead apron and a thyroid collar. A 10 x 10 x 1 cm
3
 air 
cell was placed between the patient and operation table to record the entrance dose and 
used to calculate dose area product (DAP). Five most frequently used x-ray tube 
angulations [169] were simulated at seven different tube voltages (from 60 kV to 120 kV) 
with 10
8
 photon histories. Doses to radiosensitive organs per DAP and effective doses per 
DAP for the patient and physician were calculated (shown in Table 2.7 and Table 2.8). A 
conclusion was reached that indicated the dosimeter-based method may overestimate the 
effective dose per DAP for physicians. 
 
Table 2.7   Effective dose per DAP (mSv/(Gy-cm
2
)) for the patient [32] 
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Table 2.8   Effective dose per DAP (µSv/(Gy-cm
2
)) for the physician [32] 
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CHAPTER 3   PATIENT DOSES AND PROJECTION ANGLE IN CONE BEAM 
CT 
3.1   Introduction 
There is frequently a pressing clinical need to provide CT capability during 
procedures performed in interventional radiology and in the operating room setting. 
Diagnostic information obtained from a CT examination is often more valuable than that 
obtained in traditional projection imaging [170, 171], and offers important medical 
information to the clinician in a timely manner [172]. CT imaging in the interventional 
suite with image intensifier based systems was attempted, but found to be unsatisfactory 
because of difficulties associated with a reduced dynamic range and image distortion. 
[173, 174] Flat panel detector CT systems are now increasingly being utilized instead of 
image intensifiers in CT interventional procedures [175]. Advantages of flat panel 
detectors over image intensifiers include excellent contrast resolution performance as 
well as distortion-free images. Interventional CT imaging is most commonly achieved by 
the use of flat panel detectors that are mounted on a C-arm. In addition, flat panel 
detectors have been mounted onto conventional CT gantries with the hope of attaining 
improved spatial resolution, as well as a superior level of mechanical stability [176].  
It is recognized that CT imaging delivers relatively high doses to patients who 
undergo this type of radiological examination [3]. CT currently accounts for about 12% 
of all diagnostic examinations in the United States, whereas it is responsible for about 
half the medical radiation doses [177]. The high dose associated with CT is increasingly a 
source of concern in the medical imaging community [178, 179]. As a result, there is 
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considerable interest in investigating ways whereby patient doses can be reduced without 
adversely affecting diagnostic information [178, 179]. One method of reducing patient 
dose in CT is the utilization of x-ray tube modulation as the x-ray tube rotates around the 
patient [180, 181]. With angular tube modulation, the x-ray beam intensity (mA) is 
increased for thicker projections, and reduced for thinner projections, to equalize the x-
ray beam intensity at the CT detector at all x-ray tube projection angles. Use of mA 
angular x-ray beam modulation is expected to reduce patient doses with no corresponding 
increase in image mottle because the noise in the reconstructed image is generally 
dominated by the projections with the lowest signal intensities [180].  
At x-ray beam qualities used in CT imaging, x-ray beam transmission through an 
average adult abdomen is only in the order of ~ 0.3 % [182]. As a result, absorbed doses 
to organs close to the entrance will be much higher than absorbed doses to those organs 
that are close to the patient exit. For image reconstruction purposes, however, the x-ray 
attenuation in an Anterior-Posterior (AP) projection would be similar to the attenuation 
from the corresponding Posterior-Anterior (PA) projection [183, 184]. It is therefore 
possible to reduce the x-ray beam intensity for projections that increase patient radiation 
risks, and vice versa [185]. A commercial scanner that offers this capability is currently 
being introduced into clinical practice [186]. Minimizing (or switching off) the tube 
current for AP projections when performing CT scans in young females could help 
minimize the risk of breast cancer and offer a technologically superior alternative to the 
use of breast shields [187, 188]. 
To quantify any dose saving that could be achieved by the use of mA modulation 
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in CT requires an explicit understanding of how patient doses vary during x-ray tube 
rotation. In this study, we investigated how doses to radiosensitive organs and the 
corresponding effective dose are influenced by x-ray tube projection angles for two cone 
beam CT geometries. Our study focused on chest and abdominal imaging, where tube 
current modulation schemes are most likely to result in significant patient dose savings.  
3.2   Method 
3.2.1   Cone Beam CT  
Cone beam CT systems use a large area flat panel detector, with dimensions that 
are about 40 cm on each side [173, 189]. One rotation of a cone beam CT system 
provides coverage over a large body region such as the whole head, the chest, or 
abdomen. The pixel size of a typical flat panel detector is approximately 200 m. One 
rotation of an x-ray tube with a 40 cm wide flat panel detector could thus generate up to 
2,000 tomographic images. By contrast, a conventional 64 slice multi-detector CT 
scanner has 64 detectors each with a width of ~ 0.6 mm. One rotation of the x-ray tube in 
a conventional CT scanner generates 64 tomographic images, each with a thickness of 0.6 
mm. To achieve the same anatomical coverage as a cone beam CT scanner with a 40 x 40 
cm
2
 flat panel detector, the MDCT would need to perform approximately 10 axial 
rotations.  
Two types of cone beam CT that utilize flat panel detectors to capture the x-ray 
beam transmitted through a patient were modeled. One has the flat-panel detector and x-
ray tube mounted in a conventional CT gantry (Gantry CT), and the other has the x-ray 
tube and flat panel detector CT scanner mounted on a C-arm mounting (C-Arm CT), as 
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depicted in Figure 3.1. The Gantry CT is described in detail by Gupta et al [176] and the 
C-arm CT is described in detail by Kyriakou et al [190]. Table 3.1 provides a summary 
of the key technical details for both cone beam CT systems, including Focus to Isocenter 
Distance (FID), Focus to Detector Distance (FDD), detector size and matrix size, long 
patient axis (i.e., z-axis) coverage and axial field of view.  
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Figure 3.1   Geometry of the CT modalities A: Gantry CT, B: C-Arm CT. 
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Table 3.1   Technical details of Gantry CT and C-Arm CT. 
Parameter Gantry CT C-Arm CT 
Focus to Isocenter Distance (FID)  (cm) 57 78.5 
Focus to Detector Distance (FDD) (cm) 93 120 
Detector Size (cm
2
) 40×30 40×30 
Matrix Size 2048×1536 1280×1024 
z-axis Coverage (cm) 18 20 
Axial Field of View (cm) 25 26 
 
We investigated the effects of added Al filtration to the x-ray tube. Normal 
radiographic x-ray tubes typically have added filtration of about 2.5 mm Al and half 
value layers of about 3 mm Al, whereas in CT imaging, filtrations and half value layers 
can be substantially higher. A recent study has reported a half value layer of 5.6 mm Al 
for a Cone Beam [191] and added filtrations can approach 9.5 mm Al equivalence in CT 
system when operated at 125 kV [192, 193]. In this study, dose computations were 
performed using three values of added Al filtration. 2.5, 6, and 9.5 mm Al were 
investigated to cover the range of values that might be encountered in cone beam CT. 
 
3.2.2   PCXMC 
PCXMC is a software package that can be used for calculating average absorbed 
organ doses and the corresponding effective dose to a patient undergoing a diagnostic x-
ray examination [37].
 
We used version 2.0.1 which calculates individual organ doses, as 
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well as the corresponding effective dose using the tissue weighting factors recommend by 
the International Commission on Radiological Protection (ICRP) in Publication 103 [194]. 
The anatomical data are based on the slightly modified models originating from the 
mathematical hermaphroditic phantom models of Cristy and Eckerman [195] with a 
nominal age of 30. In this study, we used a standard size adult phantom which weighed 
73.2 kg, with a height of 178.6 cm that corresponds to a Body Mass Index of 22.9 kg/m
2
. 
For all our simulations, the arms were kept within the phantom and their attenuation was 
therefore included in the calculated organ doses.  
PCXMC allows the user to define the patient irradiation geometry, where the 
isocenter is always located in the geometrical center of the ellipse that defines the patient 
cross-section. The user can define the image area both in vertical and horizontal 
directions, FDD, as well as the patient-exit to detector distance. Definition of these 
parameters permits the simulation of the irradiation geometries for both C-arm and 
gantry-CT. The most important parameter that we investigated for a given gantry was the 
projection angle (). Figure 2A shows the projection angles. A 90 angle corresponds to 
a posteroanterior (PA) projection, and a 270 corresponds to an anteroposterior (AP) 
projection. A projection angle of 0, which is also equivalent to 360, corresponds to a 
left lateral projection, and a projection angle of 180 is a right lateral. Figure 2B shows a 
coronal view of the phantom where the vertical axis from the mid-thigh region to the 
head is defined by a z value. The six specific z values used in this study are shown in 
Figure 2B, which range from the pelvic region (z = 12) to the upper chest region (z = 62). 
To compute doses all factors that influence the x-ray beam quality have to be 
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defined. All of our computations used a tungsten target with a 15 anode angle. The x-ray 
tube voltage in human CT imaging is typically 120 kV. Lower voltages of 80 kV may be 
used when imaging pediatric patients or when iodinated contrast media has been 
administered to the patient [196, 197], and higher x-ray tube voltages (140 kV) may be 
used to increase penetration through larger patients or to reduce the incidence of beam 
hardening image artifacts [198]. To cover this range of values that is likely to be 
encountered in clinical practice, we investigated three x-ray tube voltages (i.e., 80, 120, 
and 140 kV). All the calculations performed in this study were performed at a constant x-
ray tube output and the x-ray tube voltage was kept constant as the x-ray tube rotates 
around the patient.  
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Figure 3.2   (A) Axial view of the phantom showing how the beam rotates around the 
phantom at 15° increments. (B) Coronal view of the phantom taken from PCXMC 
software, showing z values (in centimeters) of the beam center we used in PCXMC (12 
cm to 62 cm). The patient phantom is shown in the prone position. 
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3.2.3   Dose calculations 
To calculate patient doses in a CT examination process, we kept the x-ray beam 
parameters identical for both Gantry CT and C-arm CT irradiation geometries (See 
Figure 3.1). Radiation doses, including organ doses and effective dose, were generated 
for a single projection at every 15 to simulate the X-ray tube rotating around the patient 
(See Figure 3.2A), and six z locations were investigated that covered the patient body 
trunk (z = 12, 22, 32, 42, 52, 62 cm) (See Figure 3.2B). In our study, all dose 
calculations made use of approximately 2 million photons. A computation for each 
projection typically took ~ 60 seconds on a 3 GHz dual-core CPU PC with an 8GB RAM. 
The default x-ray tube voltage was 120 kV, and the default Al filtration was 6 mm, 
which were used in all calculations unless otherwise specified. Table 3.2 shows the x-ray 
tube air kerma per unit of tube current exposure time product (in Gy/mAs) as a function 
of x-ray tube voltage (kV) with the x-ray beam filtrations (mm Al) used in our 
experiments, which were obtained from the PCXMC software package. Data in Table 2 
enable average organ doses and effective doses computed in this study to be directly 
related to the x-ray tube air kerma output.  
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Table 3.2   X-ray tube air kerma per unit of tube current-exposure time product 
(μGy/mAs) at 1 m distance with different tube voltage and filtration settings. 
Tube Voltage (kV) 
Filtration (mm Al) 
2.5 6 9.5 
80 55 24 13 
120 118 65 43 
140 156 93 64 
 
Average absorbed doses were generated and recorded for five organs that are 
currently considered to the most radiosensitive for the induction of the stochastic effect of 
carcinogenesis. These five organs are the breast, colon, lung, RBM, and stomach which 
all have a tissue weighting factor of 0.12 [194], and thus are deemed by the ICRP to 
account for 60% of any population-averaged radiation detriment arising from uniform 
whole body irradiation. We also obtained values of patient effective doses generated by 
PCXMC, that were obtained using organ weighting factors provided in ICRP Publication 
103 [194]. Normalized values of organ doses and effective dose were obtained by 
dividing each computed dose by the appropriate mAs values, and expressed as Gy/mAs 
for organ doses and Sv/mAs for effective doses.  Computed data points in all graphs 
were fitted into spline curves for ease of viewing. 
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3.3   Results 
3.3.1   Average Organ Doses  
Figure 3.3 through Figure 3.7 show the absorbed doses to individual organs as a 
function of X-ray projection angle, where the normalized organ doses are plotted using a 
logarithmic scale. Table 3.3 provides a summary of the maximum and minimum 
normalized doses and the maximum to minimum dose ratios to all five organs for the 
Gantry CT and C-Arm CT geometries, respectively. Data in Table 3.3 show that 
maximum to minimum ratios of organ dose as a function of x-ray tube angle () were ~ 
2.2 for the lungs, ~ 3.7 for the colon, ~ 5.9 for the red bone marrow, ~ 19.8 for the breast, 
and ~ 36 for the stomach. 
Table 3.4 shows how radiation doses to all five organs vary with the principal 
projections in CT imaging (i.e., AP; PA; Lateral). Organ doses presented in Table 3.4 
were normalized by the organ doses averaged over all 24 projections that we investigated. 
For example, an AP projection normalized dose of 2 µGy/mAs, when the average 
normalized dose per projection is 1 µGy/mAs, would be expressed as 200%. As  varies, 
data in Table 3.4 and Figures 3.3 through 3.7 illustrate that dose distributions for the 
lung and colon are the most symmetrical, and that dose distribution for the stomach is 
highly asymmetrical.  
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Figure 3.3   Normalized breast dose (µGy/mAs) as a function of projection angle for A: 
Gantry CT and B: C-arm CT at 120 kV tube voltage. 
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Figure 3.4   Normalized colon dose (µGy/mAs) as a function of projection angle for A: 
Gantry CT and B: C-arm CT at 120 kV tube voltage. 
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Figure 3.5   Normalized lung dose (µGy/mAs) as a function of projection angle for A: 
Gantry CT and B: C-arm CT at 120 kV tube voltage. 
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Figure 3.6   Normalized red bone marrow dose (µGy/mAs) as a function of projection 
angle for A: Gantry CT and B: C-arm CT at 120 kV tube voltage. 
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Figure 3.7    Normalized stomach dose (µGy/mAs) as a function of projection angle for 
A: Gantry CT and B: C-arm CT at 120 kV tube voltage. 
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Table 3.3   Normalized organ dose maxima and minima for CT scans performed at 120 
kV. 
Organ 
Gantry CT C-Arm CT 
Dose 
Maximum 
(µGy/mAs) 
Dose 
Minimum 
(µGy/mAs) 
Ratio 
Dose 
Maximum 
(µGy/mAs) 
Dose 
Minimum 
(µGy/mAs) 
Ratio 
Breast 
z = 52 
235.1 11.2 21.0 120.0 6.5 18.5 
Colon 
z = 22 
126.7 34.5 3.7 69.7 18.6 3.7 
Lung 
z = 52 
130.9 61.2 2.1 76.7 33.1 2.3 
RBM 
z = 22 
58.7 9.7 6.0 31.5 5.4 5.8 
Stomach 
z = 32 
243.4 6.4 38.2 127.9 3.8 33.7 
 
 
 
Table 3.4   Organ doses as a function of projection angle. Organ doses are expressed as a 
percentage, with the average dose over all 24 projections being 100%.  
Organ LLAT (0) PA (90) RLAT (180) AP (270) 
Breast 
z = 52 
82.0% 32.7% 81.9% 161.8% 
Colon 
z = 22 
52.9% 76.2% 61.8% 180.2% 
Lung 
z = 52 
61.9% 136.4% 69.0% 111.4% 
RBM 
z = 22 
45.1% 219.1% 45.2% 52.7% 
Stomach 
z = 32 
111.6% 52.8% 6.7% 199.8% 
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Figure 3.8 shows the average normalized dose to each organ varying with patient 
long axis location z, where these data were obtained by averaging the normalized organ 
doses over all x-ray tube projection angles and both cone beam geometries. For the breast 
and lung, the highest absorbed dose occurs at z = 52 cm. For the colon, the highest 
absorbed dose was at z = 22 cm, and for the stomach at z = 32 cm. For RBM, the average 
organ dose showed relatively small changes with the location of the x-ray tube along the 
patient long axis.  
 
Figure 3.8   Normalized absorbed doses to radiosensitive organs (µGy/mAs) at each 
patient long axis location (z) for Gantry CT and C-Arm CT computed at 120 kV tube 
voltage, averaged over all projection angles. 
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3.3.2   Effective Doses 
Figure 3.9 illustrates how normalized effective dose varies with x-ray tube angle 
for body imaging, where the effective dose has been plotted on a logarithmic scale. Table 
3.5 provides a summary of the maximum and minimum normalized doses to the organs 
under investigation for the Gantry CT and C-Arm CT. Data in Table 3.5 reveal that for 
chest and abdominal CT, maximum to minimum effective dose ratios as a function of x-
ray tube projection angle were ~ 2.7 and ~ 4.0, respectively.  
 
Figure 3.9   Normalized effective dose (µSv/mAs) as a function of projection angle for 
Gantry and C-arm CT of the chest and pelvis/abdomen regions at 120 kV tube voltage. 
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Table 3.5   Normalized effective dose maxima and minima for Gantry CT and C-Arm CT 
generated at 120 kV. 
Body 
Region 
Gantry CT C-Arm CT 
Dose 
Maximum 
(µSv/mAs) 
Dose 
Minimum 
(µSv/mAs) 
Ratio 
Dose 
Maximum 
(µSv/mAs) 
Dose 
Minimum 
(µSv/mAs) 
Ratio 
Chest 
z = 52 
51.8 17.9 2.9 29.0 11.5 2.5 
Abdomen 
z = 32 
48.0 11.9 4.0 26.7 6.7 4.0 
 
Table 3.6 demonstrates how normalized effective dose varies with patient long 
axis dimension z. The lowest effective doses occur at z ~ 12 cm in the pelvic region, and 
the highest effective doses are at z ~ 52 cm, which is the region of the breast. Overall, 
body effective doses vary by no more than a factor of two when the location of the x-ray 
tube is varied along the long patient axis.  
 
Table 3.6   Normalized effective doses (µSv/mAs) averaged over angle at different z 
location for Gantry CT and C-Arm CT (computed at 120 kV). 
z (cm) Gantry CT C-Arm CT 
12 18.6 10.5 
22 21.5 12.4 
32 28.0 15.9 
42 30.1 18.3 
52 34.9 19.9 
62 17.2 11.1 
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3.3.3   X-ray Beam Quality 
Figure 3.10 shows how the normalized and relative effective doses at z equal to 
52 cm (corresponds to chest scan) vary with x-ray tube projection angle for the range of 
x-ray tube voltage normally encountered in CT (i.e., 80 to 140 kV). Relative effective 
doses were obtained by dividing normalized effective doses by the average value 
obtained over all projection values, so that the average of the relative effective doses is 
1.0. Increasing the x-ray tube voltage from 80 kV to 140 kV results in an approximately 
five fold increase in patient doses, but relative patient doses as a function of projection 
angle were approximately independent of the choice of x-ray tube voltage.  
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Figure 3.10   Effective dose as a function of projection angle for different voltages in the 
chest region at Gantry CT under 120 kV tube voltage (A: normalized values; B: relative 
values). 
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Figure 3.11 displays how the normalized and relative effective doses at z equal to 
52 cm (corresponds to chest scan) vary with x-ray tube projection angle for x-ray tube 
filtrations ranging from 2.5 mm Al to 9.5 mm Al. Increasing the x-ray tube filtration from 
2.5 mm Al to 9.5 mm Al reduced patient doses by approximately a factor of two, but 
relative patient doses as a function of projection angle were approximately independent 
of the x-ray tube filtration.  
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Figure 3.11   Effective dose as a function of projection angle for different filtrations in 
the chest region at Gantry CT under 120 kV tube voltage (A: normalized values; B: 
relative values). 
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3.4   Discussion 
Maximum doses for the breast, lung and stomach shown in Figure 3.8 are 
approximately equal. By contrast, the maximum red bone marrow dose is about four 
times lower. Cone beam CT only irradiates a fraction of RBM, whereas all of small 
organs such as the stomach, or most of the larger organs such as the lung would be 
irradiated. Since the computed doses are obtained by averaging the deposited energy over 
the whole organ, those organs whose anatomy is larger than the x-ray beam will always 
result in lower organ doses. The maximum dose to the colon is intermediate between the 
higher doses to the breast, lung, and stomach, and the lower doses to the red bone marrow. 
The colon is relatively large with a long axis extent of ~ 27 cm, is not compact and is 
adjacent to a significant amount of bone in the pelvis. All of these three factors would 
likely to reduce organ doses in cone beam CT relative to organs such as the breast, 
stomach, and lung.  
There were only very minor differences between the two gantries for the angles at 
which any given organ dose was highest and lowest. The average of the dose maxima for 
the two cone beam CT geometries (i.e., Gantry CT/C-Arm CT) for the five organs 
investigated (Table 3.2) was 1.85 ± 0.10. The ratio of the focus to isocenter distances for 
the two geometries is 1.38 (i.e., 78.5/57), which would be expected to result in X-ray tube 
output differences of a factor of 1.89. In our simulations, organ doses were predominantly 
affected by choice of focus to isocenter distance. Partial irradiation of organs and tissues 
in our study did not result in any marked differences in the doses to the five most 
radiosensitive organs. However, when smaller organs such as the gonads are irradiated, 
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potential difference in organ doses caused by geometric factors could be possible.  
Our data covered only the five most sensitive organs in the body, including 
superficial organs such as the breast, extended organs such as the red bone marrow, and 
organs that have moderate size such as the stomach. Organs and tissues that are of lesser 
importance for patient carcinogenic risk estimation purposes include the thyroid, liver, 
bladder, and esophagus. These latter organs, which would account for about 22% of the 
total cancer radiation risk from uniform irradiation, were not explicitly investigated. 
Knowledge of the anatomical location and physical characteristics of any organ [199] 
could be combined with our data to offer guidance regarding the expected variation of 
dose to such organs as a function of projection angle. For example, the ratio of bladder 
dose as a function of x-ray tube angle would most likely be similar to our data on the 
stomach, given the general similarity of the sizes and radial locations of these two organs.  
Quantitative radiation risk estimates require organ doses, and must take into 
account both the age and sex of any exposed individual. The radiation risk for breast 
cancer, for example, varies by two orders of magnitude between the ages of 20 and 80, 
and is much lower in males than in females [73]. Organ dose data presented in Figures 
3.3 through 3.8 can be used to evaluate how tube current modulation schemes might 
impact on patient radiation risk. Switching off the x-ray tube for a total of 60 for AP 
projections (i.e., 240 to 300) and compensating for this by doubling the tube current for 
PA projections (i.e., 60 to 120) is technically possible in cone beam CT [185]. Use of 
this modulation would reduce breast doses, and the corresponding breast cancer radiation 
risks, by about 30%.  
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Variations in effective dose with x-ray tube projection angle are generally much 
smaller than those for organs and tissues such as the breast and stomach. This is to be 
expected, given that the effective dose takes into account all irradiated organs and tissues. 
Switching off the x-ray tube for 60 for AP projections (i.e., 240 to 300) and doubling 
the tube current for the PA projections to 60 degree (i.e., 60 to 120) would reduce body 
effective doses by ~ 15%. It is important to note that although computed effective doses 
are not radiation risk quantities, they provide a general estimate of the amount of 
radiation received by a patient in a given examination [48]. Effective doses can be used to 
compare doses from disparate types of radiological examinations such as a chest 
radiograph, chest CT scan, and a nuclear medicine ventilation/perfusion scan [44, 200]. 
Effective doses may also be compared with other benchmark doses such as natural 
background and regulatory dose limits. In the US, for example, natural background 
exposure is ~ 3 mSv/year [177], and annual regulatory dose limits are 50 mSv/year for 
radiation workers and 1 mSv/year for members of the public [192]. 
Data in Figures 3.10 and 3.11 exhibit the expected changes in absolute values of 
effective dose with x-ray beam quality. Relative effective doses in chest CT as a function 
of x-ray tube angle are approximately independent of x-ray beam quality. We also 
investigated the behavior of absolute and relative dose with x-ray beam quality in 
abdominal CT. The results obtained in abdominal CT were qualitatively and 
quantitatively similar to the ones depicted in Figures 3.10 and 3.11. Since effective doses 
are computed on the basis of individual organ doses, it is also likely that relative organ 
doses as a function of x-ray tube angle are approximately independent of x-ray beam 
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quality. In cone beam CT, organ or effective dose savings achievable from the use of 
angular beam modulation are likely independent of x-ray beam quality.  
3.5   Conclusion 
There are major differences in organ and effective dose as the x-ray tube rotates 
around the patient. Our results suggest that the use of x-ray tube current modulation could 
produce substantial reductions in organ and effective dose for body imaging with cone 
beam CT.  
Our data permit researchers and CT designers to quantify how specific x-ray tube 
current modulation schemes will impact on patient dose. Data presented in Figures 3.3 
through 3.8, together with the ratios presented in Table 3.3, permit a quantification of 
how mA modulation schemes in cone beam CT will affect patient risks, taking into 
account patient demographics. Data presented in Figure 3.9 and Table 3.4 permit 
quantification of how mA modulation schemes will impact on patient effective doses. 
Understanding how organ and effective doses are impacted by x-ray tube current 
modulation is important for management of patient doses in cone beam CT. Optimizing 
the design and operation of cone beam CT scanners will help minimize patient doses 
without adversely impacting diagnostic performance [201]. 
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CHAPTER 4   X-RAY TUBE CURRENT MODULATION AND PATIENT DOSES 
IN CHEST CT 
4.1   Introduction 
Clinical use of CT imaging has grown substantially over the past 30 years and it is 
now estimated that nearly 70 million examinations are performed in the United States 
every year [177]. For indicated examinations there is a duty by the medical imaging 
community to minimize the amount of radiation used to perform examinations that use 
ionizing radiations without sacrificing valuable diagnostic information required for 
optimal patient care [202]. Optimization of indicated radiological examinations is known 
as keeping patient exposures ALARA (As Low As Reasonable Achievable) by 
elimination of all unnecessary radiation [179, 203].  
Tube current modulation (mA modulation) has recently been introduced into 
clinical practice since it can reduce patient dose without sacrificing image quality or 
diagnostic performance [204, 205]. Tube current modulation reduces tube current (i.e., x-
ray) intensity for less attenuating path lengths through the patient, and increase tube 
currents for path lengths that have greater attenuation [180, 206].  Chest CT is an area 
where x-ray tube current modulation is likely to have high dose savings [207]. The chest 
and adjacent region contains a number of radiosensitive organs and tissues, including the 
female breast, lungs, red bone marrow, the stomach, and the thyroid gland [194]. There 
are marked differences in x-ray beam attenuation in the chest region as a function of x-
ray tube angle as well as along the patient axis [206, 208]. Knowledge of how patient 
effective doses vary with x-ray tube projection angle as well as longitudinal x-ray tube 
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location are important prerequisites for quantifying potential patient dose savings that 
may be achieved by any tube current modulation scheme [209].  
In this paper we investigate how patient effective doses vary as a function of x-ray 
projection angle as well as long patient axis for the irradiation geometry of a conventional 
CT scanner used to perform chest CT examinations. Relative effective dose data are 
combined with longitudinal and angular modulation schemes to shed light on the 
quantitative dose savings that tube current modulation schemes could offer to adult 
patients undergoing chest CT examinations.  
 
4.2   Methods 
4.2.1   CT Simulations 
We used software package PCXMC 2.0.1 developed by STUK (Radiation and 
Nuclear Safety Authority, Helsinki, Finland), to calculate patient doses in any type of 
simulated x-ray examinations. PCXMC calculates absorbed doses to organs that of 
interest in radiological protection, as well as the corresponding effective dose obtained 
using ICRP 103 tissue weighting factors [194]. In this study, we used an adult phantom 
with the height of 178.6 cm and mass of 73.2 kg, and whose arms were in place at the 
phantom sides [195, 210]. Figure 4.1 shows the mathematical anthropomorphic phantom 
which ranges from the base of the lung (z = 36) to the shoulder region (z = 72). The lungs 
extend from z = 43.5 to z = 67.5; the heart extends from z = 44 to z = 56.  
80 
 
 
Figure 4.1   Scheme of the projection area investigated (from z = 36 to z = 72). 
 
We simulated chest CT examinations performed with a gantry CT irradiation 
geometry. The source to image receptor distance (SID) was 93 cm and source to isocenter 
distance was 57 cm. The x-ray beam width was set to 40 cm, which is equal to the lateral 
extent of the patient, and the beam height along the long patient axis was 4 cm. The 
isocenter of the simulated CT scanner was always located at the geometrical center of the 
patient. Simulations were performed as a function of x-ray tube projection angle (), with 
an angle of 90 corresponds to a posteroanterior (PA) projection, 270 corresponds to an 
anteroposterior (AP) projection, and an angle of 0 corresponds to a left lateral 
projection, and an angle of 180 is a right lateral projection.  
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4.2.2   Effective Doses  
All patient dose calculations were performed using an x-ray tube voltage of 120 
kV which is the value most commonly employed in clinical chest CT scanning [207]. The 
x-ray tube employed a tungsten target with a 15 anode angle, with a total of 8 mm 
aluminium filtration. No beam shaping filter was used in our dose computations. A 
constant x-ray tube current-time product was used for each projection. Each individual 
dose calculations made use of approximately 2 million photons, and required a 
processing time of ~ 60 seconds on a 3 GHz dual-core CPU PC with an 8GB RAM. 
At each long patient axis location, effective doses were determined at 15 
intervals of the angle  which ranged from 0 to 345, and resulted in 24 values of 
effective dose at a constant x-ray tube output. We also computed effective doses at nine 
locations of the patient long axis location from z = 38 to z = 70, where a value of z = 32 
represents an x-ray beam that extends from z = 30 to z = 34. The long patient axis range 
(z = 36 to z = 72) corresponds to a scan length of 36 cm. 
 
4.2.3   Tube Current Modulation 
Table 4.1 shows the angular modulation schemes investigated. Each column in 
Table 4.1 shows the angular modulation scheme which specifies the weighting to be 
allocated to each of the 24 angles. The lowest weightings are allocated to the AP and PA 
projections, and the highest weightings are allocated to the lateral projections. Table 4.2 
shows the longitudinal modulation schemes that were investigated. Data in each column 
in Table 4.2 specify the relative weightings allocated to each of the nine long patient axis 
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locations. The lowest weightings are allocated to the regions where x-ray transmission is 
increased (z = 54 to 58 in Figure 4.1), and the highest weightings are allocated to 
shoulder (z ~ 70) and abdominal (z ~ 38) regions. For each column in Tables 4.1 and 4.2, 
the average weighting is equal to unity, and the ratio of the maximum to minimum 
weighting value (modulation amplitude) is R, where the latter ranges from 1.5 to 5.  
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Table 4.1   Angular modulation factors with different modulation amplitudes (R) at each 
projection angle. 
Projection Angle 
(degree) 
R = 1.5 R = 2 R = 3 R = 5 
0.00 1.20 1.33 1.50 1.67 
15.00 1.13 1.22 1.33 1.44 
30.00 1.07 1.11 1.17 1.22 
45.00 1.00 1.00 1.00 1.00 
60.00 0.93 0.89 0.83 0.78 
75.00 0.87 0.78 0.67 0.56 
90.00 0.80 0.67 0.50 0.33 
105.00 0.87 0.78 0.67 0.56 
120.00 0.93 0.89 0.83 0.78 
135.00 1.00 1.00 1.00 1.00 
150.00 1.07 1.11 1.17 1.22 
165.00 1.13 1.22 1.33 1.44 
180.00 1.20 1.33 1.50 1.67 
195.00 1.13 1.22 1.33 1.44 
210.00 1.07 1.11 1.17 1.22 
225.00 1.00 1.00 1.00 1.00 
240.00 0.93 0.89 0.83 0.78 
255.00 0.87 0.78 0.67 0.56 
270.00 0.80 0.67 0.50 0.33 
285.00 0.87 0.78 0.67 0.56 
300.00 0.93 0.89 0.83 0.78 
315.00 1.00 1.00 1.00 1.00 
330.00 1.07 1.11 1.17 1.22 
345.00 1.13 1.22 1.33 1.44 
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Table 4.2   Longitudinal modulation factors with different amplitudes (R) at each patient 
long axis positions (z). 
z (cm) R = 1.5 R = 2 R = 3 R = 5 
38 1.18 1.30 1.46 1.64 
42 1.18 1.30 1.46 1.64 
46 0.96 0.92 0.84 0.73 
50 0.96 0.92 0.84 0.73 
54 0.79 0.65 0.49 0.33 
58 0.79 0.65 0.49 0.33 
62 0.92 0.87 0.81 0.76 
66 1.05 1.08 1.14 1.20 
70 1.18 1.30 1.46 1.64 
 
We investigated the importance of angular modulation alone, longitudinal 
modulation alone, as well as the combination of both angular and longitudinal 
modulation. Calculations were performed for a range of modulation intensities as defined 
by the parameter R. A value of R equal to 1 corresponds to no tube current modulation. 
We also investigated the use of modulation schemes designed to minimize patient doses 
by switching off the x-ray beam at the projection angles that have the highest doses, and 
compensating for this by doubling the x-ray beam intensity for the opposite projections.  
A review was performed of published modulation schemes in the scientific 
literature that pertain to chest CT examinations in normal sized adult patients to obtain 
values of R that are used in current longitudinal and angular modulation schemes in chest 
CT examinations [187, 206, 209, 211]. Values of R for longitudinal modulation were 
obtained by comparing the maximum to minimum tube currents along the patient axis 
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within the chest region. In clinical practice, angular modulation varies with long patient 
axis location (z). For angular modulation, we therefore obtained a range of R values that 
span the range of the largest and smallest amounts of angular modulation within the chest 
region. 
 
4.3   Results 
4.3.1   Relative Effective Doses 
Values of relative effective dose as a function of x-ray tube angle, and long 
patient axis, are summarized in Table 4.3. As expected, effective dose maxima occur for 
AP projections at the location of the breasts (i.e., z ~ 52; projection angle ~ 210° and ~ 
330°). The lowest effective doses are at 30° and 150° (oblique angles) which are the 
projections that would minimize the absorbed doses to the radiosensitive breasts.  
Figure 4.2A shows effective dose as a function of projection angle when 
averaged over all 9 long patient axis values. Figure 4.2B shows how the effective dose 
varies with long patient axis location when averaged over all 24 x-ray tube projection 
angles. The lines shown in Figure 4.2 are fitted spline curves added for ease of viewing.  
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Table 4.3   Normalized effective doses with different projection angles (θ) and patient 
long axis locations (z). 
                  z(cm)   
θ(degree) 
38 42 46 50 54 58 62 66 70 
0 0.95 0.74 0.71 1.63 1.57 0.54 0.38 0.27 0.64 
15 0.85 0.71 0.75 1.39 1.33 0.55 0.41 0.29 0.54 
30 0.94 0.82 0.85 1.04 0.95 0.61 0.48 0.34 0.46 
45 1.04 0.93 0.96 0.95 0.87 0.70 0.55 0.40 0.40 
60 1.11 1.01 1.04 1.06 0.97 0.77 0.60 0.44 0.36 
75 1.13 1.06 1.10 1.19 1.09 0.82 0.64 0.46 0.33 
90 1.11 1.06 1.12 1.26 1.16 0.85 0.65 0.46 0.31 
105 1.04 1.02 1.10 1.19 1.09 0.82 0.64 0.46 0.33 
120 0.92 0.95 1.03 1.06 0.97 0.78 0.60 0.44 0.35 
135 0.81 0.85 0.93 0.96 0.87 0.70 0.55 0.40 0.41 
150 0.68 0.73 0.83 1.04 0.96 0.61 0.47 0.34 0.46 
165 0.56 0.61 0.72 1.39 1.33 0.55 0.41 0.29 0.54 
180 0.51 0.56 0.68 1.62 1.59 0.55 0.38 0.27 0.63 
195 0.60 0.64 0.80 1.96 1.92 0.67 0.43 0.30 0.70 
210 0.84 0.81 0.94 2.58 2.57 0.80 0.50 0.36 0.75 
225 1.12 1.01 1.05 2.96 2.96 0.91 0.57 0.40 0.77 
240 1.36 1.16 1.12 2.74 2.73 0.97 0.62 0.44 0.81 
255 1.55 1.27 1.16 2.79 2.78 1.01 0.64 0.46 0.83 
270 1.67 1.33 1.18 2.81 2.80 1.03 0.65 0.46 0.84 
285 1.74 1.35 1.16 2.80 2.79 1.01 0.64 0.46 0.84 
300 1.75 1.32 1.11 2.75 2.74 0.96 0.61 0.44 0.81 
315 1.67 1.23 1.04 2.94 2.93 0.90 0.57 0.40 0.78 
330 1.51 1.09 0.94 2.56 2.54 0.80 0.51 0.36 0.74 
345 1.23 0.89 0.83 1.94 1.90 0.66 0.43 0.30 0.70 
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Figure 4.2    Relative effective dose averaged by (A) projection angles and (B) patient 
long axis locations.  
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Table 4.4 shows how effective doses vary with z and . The maximum to 
minimum ratio of effective doses as a function z alone and  alone are 4.9 and 2.1, 
respectively. When both z and  are allowed to vary, the maximum to minimum ratio of 
effective doses is 11.0. 
 
Table 4.4   Key characteristics of how effective doses vary with z and  taken from Table 
4.3 
Variable 
Effective Dose Maximum Effective Dose Minimum 
Relative E z (cm)  (degree) Relative E z (cm)  (degree) 
z and  2.96 50 225 0.27 66 180 
z 1.86 50 N/A 0.38 66 N/A 
 1.42 N/A 270 0.68 N/A 150 
 
4.3.2   Dose Reductions from Modulation  
Figure 4.3 shows reductions in patient dose by use of angular modulation alone 
and longitudinal modulation alone. Reductions in patient dose from longitudinal 
modulation (alone) appear to be approximately twice those that could be achieved using 
angular modulation (alone) in chest CT imaging. Figure 4.3 shows how combining 
angular and longitudinal modulation as a function of R. Setting R to 2 for both 
longitudinal and angular modulation would reduce effective doses by 6.4%. Increasing R 
to 5 would result in effective dose reductions of 14%.  
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Figure 4.3   Dose saving rate resulted from angular modulation, longitudinal modulation 
and combined modulation with different modulation amplitudes (R). 
 
Table 4.5 shows how patient effective doses could be reduced by switching off 
the x-ray tube current for the most sensitive projections (AP), and doubling the x-ray 
beam current for the opposite projections. As the angular range over which the x-ray 
beam is switched off increases from 30 to 90, patient doses reduction rate increases 
from 6.8% to 16.4%.  
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Table 4.5   Reductions in effective doses from a modulation scheme where the tube 
current is switched off for the most sensitive projections and doubled for the opposite 
projections.  
 Scheme 1 Scheme 2 Scheme 3 
Switched off projection angles 255 to 285 240 to 340 225 to 315 
Current doubled projection angles 75 to 105 60 to 120 45 to 135 
Angular range (AP) of modulation  30 60 90 
Effective dose reduction rate (%) 6.8 11.4 16.4 
 
Table 4.6 summarizes R values estimated from graphical variations of x-ray tube 
currents in chest CT examinations taken from the scientific literature [187, 206, 209, 211]. 
Average value of R for longitudinal modulation is 2.2, and average values of R for 
angular modulation schemes range from a minimum of 1.5 to a maximum of 3.4. Data 
shown in Figure 4.3 permit a modulation R value to be converted into a corresponding 
patient effect dose reduction value. Current longitudinal x-ray tube current modulation 
schemes (Table 4.6) reduce patient effective doses by ~ 7%, and current angular x-ray 
tube current modulation schemes reduce patient effective doses by between 1.5% and 4%. 
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Table 4.6   Modulation amplitudes (R) obtained from published figures 
with clinical mA modulation in chest CT examination.  
Reference 
Modulation Parameter R 
Angular 
(Max) 
Angular 
(Min) 
Longitudinal 
Angel et al 
(2009) 
1.7 1.2 2.9 
Hundt et al 
(2005) 
4.2 1.6 1.3 
McCollough et al 
(2006) 
4.2 1.3 2.4 
Straten et al 
(2009) 
3.4 1.8 2.0 
Average 3.4 1.5 2.2 
 
4.4   Discussion 
Data presented in Table 4.3 shows how patient effective doses, obtained using the 
most recent ICRP 103 tissue weighting factors [194], vary with x-ray tube angle and x-
ray tube location along the patient axis. The absolute maximum to minimum ratio of 
effective doses was 11, showing that modulation of the x-ray tube current could offer 
substantial dose savings. It is also evident that variations of the maximum to minimum 
ratio of effective doses along the long patient axis z are more than double as large as 
those around the patient. These data therefore suggest that, in principle, longitudinal 
modulation has the potential for larger dose savings when compared with angular 
modulation alone. 
Our tube current modulations were designed to highlight both qualitative and 
quantitative features likely to be obtained from the use of x-ray tube current modulation 
in chest CT. Data presented in Figure 4.3 show how reductions in patient effective dose 
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increase with the R parameter described in this work. These data show that dose savings 
vary in an approximately exponential manner as a function of R. For longitudinal 
modulation alone, a doubling of R reduces patient effective dose by ~ 4% whereas for 
angular modulation alone, a doubling of R will reduce in patient effective dose by ~ 2%.  
These numerical estimates can be used as approximate guides for estimating the 
magnitude of patient dose savings that might be expected using current tube current 
modulation schemes designed to maintain image quality.  
Current longitudinal x-ray tube current modulation schemes shown in Table 4.6 
reduce patient effective doses by about 10%, with about one third of this reduction 
resulting from angular modulation, and the remaining two thirds resulting from 
longitudinal modulation. A recent study investigated tube current modulation in chest CT 
in a Rando phantom, and showed reductions in effective dose of ~ 7% for longitudinal 
modulation, and ~ 9% for longitudinal and angular modulation combined [209]. These 
findings of van Straten et al are therefore in excellent agreement with the results reported 
in this work in terms of the absolute level of dose reductions, as well as the relative 
importance of angular and longitudinal tube current modulation.  
Current dose modulation schemes have primarily introduced with the specific 
goal of maintaining image quality [180, 205, 212]. Tube current modulation, however, 
can also be applied to specifically minimize patient doses. X-ray attenuation of rays in an 
Anterior-Posterior (AP) projection is identical to the attenuation from the corresponding 
Posterior-Anterior (PA) projection. As a result, it is possible to reduce the x-ray beam 
intensity for projections that increase effective doses, whilst increasing the intensity of 
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the x-ray beam that results in lower effective doses. A commercial scanner that offers this 
capability has recently been introduced into clinical practice [186]. Data presented in this 
paper show that switching off the tube current for AP projections when performing CT 
scans has the potential to substantially reduce patient doses. Design of a tube current 
modulation scheme that both maintains image quality as well as minimizing patient doses 
and risks should be possible, and could offer even larger patient dose reductions.  
In chest CT, gonad doses are generally negligible, and effective doses therefore 
provide an estimate of the risk of cancer induction. It is important to note these effective 
doses are not radiation risk quantities per se [194]. Quantitative radiation risk estimates 
require organ doses, and must take into account both the age and sex of any exposed 
individual [213]. Nonetheless, effective doses are directly related to the patient cancer 
risk, and quantify the amount of radiation a patient receives in a given examination [48]. 
Relative changes in effective dose are likely to correlate well with relative changes in the 
patient cancer risk, and it is reasonable to expect a 10% reduction in effective dose to 
result in a similar reduction in the (average) patient risk.  
The principal limitations of our study is the fact that the x-ray dose simulations 
only employed a conventional x-ray beam filter, but did not include the beam shaping 
filter that is currently used in most commercial CT scanners. The use of a beam shaping 
filter clearly reduces absolute values of organ doses, and therefore the corresponding 
patient effective doses. The effect of the beam shaping filter on relative doses, however, 
is uncertain. To shed light on this topic, we compared effective dose (E) to dose length 
product (DLP) data for CT scanners, for CT systems from one commercial vendor that 
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are available in the ImPACT CT Dosimetry Calculator [38]. The average E/DLP for chest 
CT examinations in two scanners with no beam shaping filter (i.e., Siemens DR3; 
Siemens DRG1) was 18 Sv/mGy-cm, whereas the corresponding value for 16 scanners 
which do employ beam shaping filters was 19 Sv/mGy-cm. These data suggest that the 
introduction of a beam shaping filter would be unlikely to have change our relative doses 
in a major manner.  
4.5   Conclusion 
Knowledge of how effective doses are will be affected by any extant or future x-
ray tube current modulation important for optimal management patients undergoing chest 
CT examinations. The primary radiation protection objective in medical imaging 
equipment is to minimize patient doses (i.e., risks) without adversely impacting on 
diagnostic performance [201, 214]. Data presented in this study will be helpful to 
researchers investigating methods for optimizing the design of modulation schemes that 
will maintain image quality and/or minimize patient risks. In addition, our results will 
assist users of MDCT scanners to quantify the likely dose savings that are achievable 
from the application any specific tube current modulation scheme [179, 203].  
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CHAPTER 5   SCAN REGION AND ORGAN DOSES IN CT 
5.1   Introduction 
In the United States, medical imaging resulted in a per capita dose of about 3 
mSv in 2006, which corresponds to an increase of about 600% in a single generation 
[177]. Although CT scanning only accounts for ~ 17% of all medical imaging 
examinations, this modality alone accounts for approximately one half of the total 
medical collective effective dose [177]. The magnitude of the collective doses per se is of 
no concern because the individuals who are being exposed to ionizing radiation also 
benefit from the diagnostic information generated in imaging examinations [215]. 
Accordingly, current radiation protection philosophy requires imaging examinations to be 
justified (i.e., indicated) where the patient benefit exceeds any corresponding risks, 
including those from radiation [179, 203]. In addition, all indicated radiological 
examinations should adopt the As Low As Reasonably Achievable (ALARA) principle 
by ensuring that no more radiation is used than that required to obtained the required 
diagnostic information [216, 217].  
Indicated examinations can only be identified when imaging practitioners are able 
to quantify the magnitude of patient risks [215]. Quantifying and minimizing risks 
therefore rests on an understanding of the magnitude of doses to radiosensitive organs 
and tissues. Organ doses permit the operator to estimate the likelihood of producing 
deterministic or stochastic effects [8, 194]. In CT, although deterministic effects are 
relatively rare, they have occurred during CT perfusion examinations [218]. In general, 
the largest concern in CT is the stochastic risk of carcinogenesis. Cancer risks are taken 
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to be directly proportional to the organ dose, and for radiological protection purposes are 
assumed to have no dose threshold below which risk would be zero [194, 219, 220]. The 
most sensitive organs and tissues of concern in patient dosimetry are taken to be the 
female breast, lungs, colon, stomach, and red bone marrow [194].  
For a given individual and fixed x-ray beam intensity, the scan location and the 
corresponding scan length are key determinants of the amount of radiation absorbed by 
any organ or tissue [221]. In this study, we investigated how the choice of the scanned 
region relative to a specific organ affects absorbed organ doses in adults undergoing 
clinical CT examinations.  
5.2   Method 
5.2.1   ImPACT 
ImPACT Dosimetry Calculator is a software package that can be used for 
calculating absorbed organ doses to an anthropomorphic phantom undergoing a 
diagnostic CT scanner examination [38]. We used ImPACT (version 1.0) to calculate 
individual organ doses in whole body CT examinations, which uses NRPB Monte Carlo 
dose data sets produced in report SR250 for 23 CT scanners [222]. Table 5.1 lists the 13 
data sets that were used in this study, which includes the CT scanner and data set 
combinations currently available in the software package. Table 5.1 also provides key 
design characteristics for each scanner including x-ray tube voltage, as well as details of 
the combination of flat and beam shaping filters.  
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Table 5.1   Scanner models investigated from the original ImPACT data set. 
No. Maker Model 
Tube Voltage  
(kV) 
Flat Filters  
(mm) 
Shaped Filters  
(material) 
1 Siemens DR3 125 2.2 Al + 0.25 Cu None 
3 Siemens DRH 125 2.2 Al + 0.2 Cu None 
5 Picker 1200 SX 130 0.7 Al Body (Lexan) 
7 GE 8800 120 2.7 Al Body (PMMA) 
8 GE 9800 120 2.7 Al (PTFE) 
9 GE 9800 140 2.7 Al (PTFE) 
10 GE MAX 120 2.6 Al (PTFE) 
11 GE PACE 120 2.7 Al (PTFE) 
15 Philips 350 (GE3) 120 3.5 Al (Al) 
17 Philips TX 120 1.4 Al + 0.1 Cu (Al) 
18 Philips CX 120 1.4 Al + 0.1 Cu (Al) 
19 Philips LX 120 1.4 Al + 0.1 Cu (Al) 
22 Philips LX 100 1.4 Al + 0.1 Cu (Al) 
23 Philips LX 130 1.4 Al + 0.1 Cu (Al) 
 
The mathematical phantom used by the ImPACT software corresponds to an adult 
size phantom with the weight of 71.1 kg [223] as depicted in Figure 5.1 and shows the 
long patient axis parameter z that ranges from -10 cm to + 94 cm. Table 5.2 summarizes 
the geometric shapes and main dimensions of the 8 organs investigated from the phantom, 
which are represented by partial or whole ellipsoids. The arms are included in the body 
trunk, and their attenuation is included in calculations. Also shown in Table 5.2 are the 
masses of each of these eight organs that range from 20 g for the thyroid to 1.8 kg for the 
liver. These eight organs were selected because they are of primary importance in 
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radiation protection dosimetry owing to their high radiosensitivity. 
 
 
Table 5.2   The shape and key dimensions of the eight organs investigated in the 
phantom (Cristy 1980). 
Organ 
[mass in kg] 
Shape 
Inferior 
Boundary 
(z =   cm) 
Superior 
Boundary 
(z =   cm) 
Length 
Lmax (cm) 
Bladder 
[0.245] 
Ellipsoid 4.5 11.5 6.9 
Breast 
[ 0.357] 
Partial ellipsoid 47.9 56.1 8.1 
Liver 
[1.810] 
Partial elliptical cylinder 27.0 43.0 16.0 
Lungs 
[0.999] 
Half an ellipsoid 43.5 67.5 24.0 
Lower Large 
Intestine 
[0.294] 
Space between two 
coaxial elliptical cylinders 
0.0 24.0 24.0 
Upper Large 
Intestine 
[0.429] 
Space between two 
coaxial elliptical cylinders 
14.5 27.0 12.6 
Stomach 
[0.397] 
Ellipsoid 27.0 43.0 16.0 
Thyroid 
[0.020] 
Two concentric cylinders 
cut by a surface 
70.0 75.0 5.0 
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5.2.2   Scan Length 
Consider a scan of length L that is centered on a selected organ, where the latter 
has a length Lmax along the craniocaudal axis (z-axis). The relative scan length Lr was 
defined as the ratio of the scan length to Lmax using  
 
Lr = L/Lmax     (5.1) 
 
Figure 5.1A shows an example of a scan from patient long axis location (z) 27 
cm to 43 cm (i.e., corresponding to Lmax of liver) so that for this organ, the scan length of 
16 cm would correspond to Lr = 1. Figure 5.1B shows a whole body scan of length 104 
cm that corresponds to scan length Lr = 6.5 for the liver. For a given organ, Lr values less 
than unity imply a symmetrical scan from the organ center, whereas for Lr greater than 
unity, the scan length increases until the maximum z value possible are reached (i.e., z = -
10 and z = + 94).  
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Figure 5.1   Scheme of the scan region on the phantom in ImPACT software package 
used to generate (A) Dr(Lr = 1) and (B) Dmax for liver. 
 
The ImPACT software allows the user to specify the starting position and the end 
position of any given scan. As a result, the operator can control scan length together with 
the precise manner in which the scan is performed. Figure 5.2 shows three different scan 
modes of liver and stomach along the craniocaudal direction that were investigated. The 
name chosen for each scan mode indicates the starting location of the scan, which were as 
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follows: 
Center: The origin is the center along the craniocaudal axis of the organ in the 
phantom, and the scan region is expanded symmetrically inferiorly and superiorly, 
by moving both the starting position and end position. It is the default scan mode 
in this study. 
Caudal: The origin is at the caudal limit of the organ and increases incrementally 
by increasing end position toward the cranial end of the organ.  
Cranial: The origin is at the cranial limit of the organ and increases incrementally 
by increasing the end position toward the caudal end of the organ.  
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Figure 5.2   Scheme of the three different scan modes on (A) Liver and (B) Stomach 
(craniocadual cross section view), where the dots show the starting point of the scan. 
Organ dimensions and location are provided in Table 5.2.  
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5.2.3   Doses  
For a selected organ undergoing a CT scan with fixed techniques (i.e., kV; mAs; 
pitch), we obtained the maximum organ dose (i.e., Dmax) for a whole body scan from the 
thigh region (z = -10 cm) to the head (z = 94 cm). Under the same operating conditions, a 
scan of length L centered at the organ of interest has an organ dose of D(L), which 
permits the relative dose Dr to be determined using  
Dr = D(L)/Dmax     (5.2) 
Values of Dr as a function of Lr were obtained for eight organs listed in Table 5.2. 
The selected organs have longitudinal lengths (i.e., z-axis lengths) from 5 cm (thyroid) to 
24 cm (lungs and lower large intestines). In addition, these organs have anatomical 
locations that range from the cervical region (thyroid) to the lower pelvic region (i.e., 
bladder). Figure 5.1A shows a scan of the whole liver (Lmax), and as well as a whole 
body scan where the liver dose is Dmax. Division of the liver dose for Lmax by the 
corresponding value of Dmax results in the value Dr (Lr = 1).  
The default CT scanner used in this study was the GE 9800 scanner operated at 
120 kV with a 2.7 mm Al flat filter and a PTFE beam shaping filter (Dataset No.8 in 
Table 5.1). The Philips LX scanner was chosen to investigate the effect of x-ray tube 
voltage on the organ doses, because dose data are available at three x-ray tube voltages 
(i.e., 100 kV, 120 kV, and 130 kV) with all other parameters kept constant. Computations 
were performed for a nominal x-ray tube current of 100 mA, a rotation time of 1 s, and a 
CT pitch of 1. All scans were obtained using the body scan mode.  
For each simulation, we recorded the value of the volume Computed Tomography 
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Dose Index (CTDIvol), which is directly proportional to the organ dose [224]. All scans 
were performed in the body mode, so that our CTDI data relate to measurements obtained 
in a CT dosimetry phantom with a diameter of 32 cm. CTDIvol data were combined with 
organ doses to obtain values of Dmax/CTDIvol for the Philips LX CT scanner operated at 
three x-ray tube voltages between 100 and 130 kV.  
 
5.3   Results 
5.3.1   Relative Dose (Dr) 
Figure 5.3 shows plots of Dr as a function of Lr for the five longest organs that 
were investigated, namely the lungs (24 cm), lower large intestines (24 cm), liver (16 cm), 
stomach (16 cm), and the upper large intestine (12.6 cm). Figure 5.4 shows plots of Dr as 
a function of Lr for the three shortest organs that were investigated, namely the breast 
(8.1 cm), bladder (6.9 cm) and thyroid (5.0 cm). As expected, for each organ, Dr 
increases monotonically with increasing Lr, and asymptotically approaches a value of 
unity.  
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Figure 5.3   Relative dose (Dr) as a function of relative length (Lr) for the five longest 
organs investigated (on the GE 9800 scanner under 120 kV, dataset No. 8). 
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Figure 5.4   Relative dose (Dr) as a function of relative length (Lr) for the three shortest 
organs investigated (on the GE 9800 scanner under 120 kV, dataset No. 8). 
Table 5.3 shows the values of Dr (Lr =1) for each of the eight organs investigated. 
Data are provided for each of the 13 CT scanners investigated, with the corresponding 
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mean and standard deviations. Average values of Dr (Lr = 1) ranged from 0.65 ± 0.02 for 
the bladder to 0.86 ± 0.00 for the lungs. Standard deviations in Dr were all less than 0.02.  
 
Table 5.3   Relative doses (Dr (Lr = 1)) for the eight investigated organs at the 13 selected 
scanners. 
No. Maker Model (kV) Bladder Breast Liver Lungs LLI* ULI* Stomach Thyroid 
1 Siemens DR3 (125) 0.63 0.86 0.79 0.86 0.85 0.69 0.81 0.71 
3 Siemens DRH (125) 0.63 0.87 0.80 0.86 0.85 0.70 0.82 0.72 
5 Picker 
1200 SX 
(130) 
0.67 0.89 0.81 0.88 0.85 0.72 0.84 0.78 
7 GE 8800 (120) 0.67 0.84 0.80 0.86 0.85 0.71 0.83 0.77 
8 GE 9800 (120) 0.66 0.84 0.79 0.86 0.85 0.71 0.82 0.76 
9 GE 9800 (140) 0.66 0.83 0.79 0.86 0.84 0.70 0.82 0.75 
10 GE MAX (120) 0.68 0.82 0.79 0.85 0.84 0.71 0.82 0.76 
11 GE PACE (120) 0.67 0.84 0.80 0.86 0.85 0.71 0.82 0.77 
15 Philips 
350 (GE3) 
(120) 
0.65 0.86 0.80 0.86 0.85 0.71 0.82 0.75 
18 Philips CX (120) 0.64 0.84 0.80 0.86 0.85 0.70 0.82 0.74 
19 Philips LX (120) 0.64 0.85 0.80 0.86 0.85 0.70 0.82 0.74 
22 Philips LX (100) 0.66 0.86 0.80 0.87 0.85 0.71 0.83 0.75 
23 Philips LX (130) 0.64 0.85 0.79 0.86 0.85 0.70 0.82 0.73 
Mean 0.65 0.85 0.80 0.86 0.85 0.71 0.82 0.75 
Standard Deviation 0.02 0.02 0.01 0.00 0.00 0.01 0.01 0.02 
* LLI: Lower Large Intestine 
* ULI: Upper Large Intestine 
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Figure 5.5 shows a plot of Dr (Lr = 1) as a function of organ length Lmax, where 
the line is a linear regression curve with least squares fit to the computed data with 
correlation coefficient (r) of 0.64. Values of Dr (Lr = 1) increase from ~0.75 for the 
smallest organ (thyroid) to ~0.86 for the longest organs (lungs and lower large intestine).  
 
Figure 5.5   Relative dose (Dr) at Lr = 1 as a function of organ length (Lmax) with 
standard errors among 14 investigated scanners. 
 
Table 5.4 shows how Dr varies with x-ray tube voltage for each organ. Values of 
Dr showed a trend of minor decreases with increasing x-ray tube voltage. At Lr = 1.0, 
increasing the x-ray tube voltage from 100 to 130 kV reduced the value of Dr by no more 
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than 0.01 for all organs except the thyroid where Dr was reduced from 0.75 to 0.73.  
 
Table 5.4   Relative dose (Dr) at different values of Lr under different tube voltages at 
Philips LX scanner. 
Organ 
Dr 
Lr = 0.25 Lr = 0.5 Lr = 1.0 Lr = 2.0 
100 
(kV) 
120 
(kV) 
130 
(kV) 
100 
(kV) 
120 
(kV) 
130 
(kV) 
100 
(kV) 
120 
(kV) 
130 
(kV) 
100 
(kV) 
120 
(kV) 
130 
(kV) 
Bladder 0.18 0.17 0.17 0.35 0.34 0.34 0.65 0.64 0.64 0.85 0.84 0.84 
Breast 0.31 0.31 0.30 0.58 0.58 0.57 0.86 0.85 0.85 0.93 0.93 0.93 
Liver 0.22 0.21 0.21 0.43 0.42 0.42 0.80 0.80 0.79 0.96 0.95 0.95 
Lungs 0.25 0.25 0.25 0.48 0.48 0.47 0.87 0.86 0.86 0.99 0.99 0.99 
Lower Large 
Intestine 
0.22 0.21 0.22 0.43 0.43 0.43 0.85 0.85 0.85 0.99 0.99 0.99 
Upper Large 
Intestine 
0.15 0.15 0.15 0.31 0.31 0.31 0.71 0.70 0.70 0.93 0.92 0.92 
Stomach 0.26 0.26 0.25 0.50 0.49 0.49 0.83 0.82 0.82 0.96 0.96 0.96 
Thyroid 0.24 0.23 0.23 0.46 0.45 0.45 0.75 0.74 0.73 0.87 0.86 0.86 
 
5.3.2   Scan Mode  
Figure 5.6 shows the differences between the three scan modes depicted in 
Figure 5.2 on absorbed doses to liver and stomach. For a scan length that covers half the 
liver, i.e. L(Lmax = 0.5), the ratio of the highest to lowest organ dose was 1.77. For a scan 
length that covers half the stomach, the ratio of the highest to lowest organ dose was 1.23.  
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Figure 5.6   Relative dose (D(L)/Dmax) for (A) liver and (B) stomach as a function of 
relative length (L/Lmax) under three different scan modes (on the GE 9800 scanner under 
120 kV, dataset No. 8). 
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5.3.3   Dmax/CTDIvol 
Table 5.5 lists ratios of [Dmax/CTDIvol] for each organ investigated, as well as the 
relative values normalized to unity at 120 kV for each organ. At 120 kV, the lowest value 
of Dmax/CTDIvol was 1.23 for the breast, and the highest was 2.22 for the thyroid. 
Reducing the x-ray tube voltage on this scanner from 120 to 100 kV reduced the value of 
[Dmax/CTDIvol] by an average of 4%. Increasing the x-ray tube voltage from 120 to 130 
kV showed an average difference in [Dmax/CTDIvol] of less than 1%.  
 
5.4   Discussion and Conclusion 
For values of Lr less than unity, Figures 5.3 and 5.4 showed that Dr is 
approximately linear with Lr. The slopes of these linear regions, however, vary with 
organ length and are generally steepest for the largest organs, and vice versa. The values 
of Dr (Lr = 1) listed in Table 5.3 may be taken as a quantitative indicator of the steepness 
of the Dr versus Lr curves depicted in Figures 5.3 and 5.4. This finding can be explained 
by consideration of the manner in which organs receive their absorbed energy, which is 
generally half from direct irradiation, and the remaining half from scattered radiation 
[225]. As the organ length increases, an increasing fraction of scatter radiation will be 
deposited in organ which thereby increases the values of Dr (Lr = 1). The mean free path 
for x-ray photons is an important parameter that influences the value of Dr (Lr = 1). X-ray 
tube voltages in CT are typically 120 kV and use heavy filtration, so the average photon 
energy is about 60 keV [226]. The linear attenuation (µ) coefficient of 60 keV photons in 
water (tissue) is ~ 0.2 cm
-1
, and with a corresponding mean free path (i.e., 1/µ) of ~ 5 cm 
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[193].  
Choice of CT scanner had essentially no effect on the value of Dr (Lr =1) given 
the very small standard deviation data provided in Table 5.3. Accordingly, the data 
presented in this study may be taken to be valid not only for CT scanners that were being 
used clinically in the early 1990s, but for any CT scanner that use fan beams and 
detection widths that are treated as essentially planar. Cone beam CT geometries, 
however, might result in Dr values different from the data depicted in Table 5.3. 
The curve fit in Figure 5.5 shows an approximately linear relationship between 
Dr (Lr = 1) and the length of the organ (Lmax). Five of the investigated organs (thyroid, 
liver, stomach, lung, and lower large intestines) fall very close to the line, and all lie 
within two standard deviations of the mean. The breast value is substantially higher, 
which is most likely a result of the superficial nature of this organ. The value of Dr (Lr = 
1) for the bladder is markedly lower than the least squares fit line, which is likely a result 
of the asymmetric nature of the irradiation of this organ. Data in Figure 5.5 show that for 
small organs with length of ~0 cm, scanning of the organ alone produces doses that are of 
~ 0.69 Dmax. For large organs with length of ~25cm, however, scanning the organ alone 
results in an organ dose that is ~ 0.86 Dmax.  
The data in Figure 5.6 show that the manner in which an organ is scanned can 
markedly impact on the organ dose. Absorbed dose in any organ is the simply the 
quotient of the energy deposited divided by the corresponding mass. For a fixed scan 
length that is less that the liver length, Figure 5.2 shows that fraction of liver that would 
be irradiated by a scan starting at the lower level of the liver would be less than a 
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corresponding scan that commences at the top of the liver.  
Table 5.4 shows that the choice of x-ray tube voltage has very little effect on Dr 
values in a normal sized adult patient. For most practical patient dosimetry applications, 
the choice of x-ray tube voltage may be neglected when considering the value of Dr. 
Although tube voltage has no significant effect on Dr, there were minor variations in the 
ratio Dmax/CTDIvol which was reduced by approximately 4% when the x-ray tube voltage 
was reduced from 120 kV to 100 kV. This finding was observed for most organs, with the 
exception of the thyroid where the Dmax/CTDIvol value was essentially independent of x-
ray tube voltage. It is important to note that recent data have shown that although dose 
conversion factors in adult CT dosimetry are essentially independent of x-ray tube 
voltage, it is necessary to take x-ray tube voltage into account when dealing with infants 
and pediatric patients [227].  
Values of Dmax/CTDIvol permit operators to estimate organ doses in normal sized 
patients from CTDIvol data provided at CT console at the end of each examination. A 
normal sized patient who undergoes a whole body scan using a CTDIvol of 20 mGy will 
receive a bladder dose of ~30 mGy, a breast dose of ~25 mGy, and a thyroid dose of ~45 
mGy. These organ doses can be obtained by multiplying the CTDIvol used to perform the 
patient examination by the appropriate Dmax/CTDIvol factor depicted in Table 5.5. For 
shorter scan lengths, the reduction in organ dose can be estimated using data presented in 
this study (Figures 5.3 and 5.4), or similar factors recently published in the scientific 
literature [228].    
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Table 5.5   Dmax / CTDIvol for the eight organs investigated at different tube voltages with 
Philips LX scanner. 
Organ 
Dmax / CTDIvol  
(Relative Dose) 
100 kV 120 kV 130 kV 
Bladder 
1.45  
(0.98) 
1.49  
(1.00) 
1.51  
(1.01) 
Breast 
1.19 
(0.97) 
1.23 
(1.00) 
1.24 
(1.01) 
Liver 
1.33 
(0.95) 
1.39 
(1.00) 
1.41 
(1.01) 
Lungs 
1.50 
(0.96) 
1.56 
(1.00) 
1.57 
(1.00) 
Lower Large Intestine 
1.17 
(0.93) 
1.25 
(1.00) 
1.27 
(1.02) 
Upper Large Intestine 
1.28 
(0.95) 
1.35 
(1.00) 
1.37 
(1.01) 
Stomach 
1.38 
(0.96) 
1.43 
(1.00) 
1.45 
(1.01) 
Thyroid 
2.19 
(0.99) 
2.22 
(1.00) 
2.17 
(0.98) 
 
For patients whose size differs from that of the anthropomorphic phantom 
depicted in Figure 5.1, doses increase with reducing patient size, and vice versa. 
Appropriate scaling factors that take into account body size have recently been published 
for both chest and body [227, 229]. Accordingly, it is possible to estimate patient specific 
organ doses for most CT scans. Obtaining a reliable estimate of organ dose is required to 
quantifying radiation risks. As in all radiation exposures, the onus on medical imaging 
practitioners is to justify all exposures, and ensure that they are minimized without 
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detracting from the valuable diagnostic information that CT imaging can provide patients 
and their physicians.  
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CHAPTER 6    ESTIMATING CANCER RISKS TO ADULTS UNDERGOING 
BODY CT 
6.1   Introduction 
One of the most important radiological protection principles in medical imaging is 
the need to ensure that any patient exposure is justified by a net benefit [220]. For each 
radiological examination, there is an implicit requirement to ensure that the patient 
benefit exceeds any corresponding radiation risk. For this reason, it is essential that 
practitioners understand the magnitude of radiation risks associated with radiological 
examinations, and how these risks vary with age and sex of the patient [230, 231]. 
Understanding patient risks is of particular importance for CT imaging where radiation 
doses are generally much higher than those in conventional radiography or fluoroscopy 
[232]. In 2006, CT accounted for ~ 17% of the total number of diagnostic examinations 
but was responsible for nearly half of the collective population dose from medical 
imaging [233].  
In CT examinations, operators are provided with the volume Computed 
Tomography Dose Index (CTDIvol) and the Dose Length Product (DLP) [234, 235]. 
CTDIvol is a measure of the intensity of radiation that is used to perform the CT 
examination, which is independent of the scan length. Multiplication of CTDIvol by the 
corresponding scan length yields the DLP, which can be taken as a measure of the total 
amount of radiation used to perform a given CT examination. The radiation absorbed by 
the patient, however, depends on the individual physical characteristics and type of CT 
examination [231, 236, 237]. For a fixed amount of radiation that is incident upon the 
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patient (i.e., DLP), reducing the patient size will increase the corresponding organ doses 
and vice versa [238]. 
The amount of radiation that is used to perform a CT examination (DLP) is 
known to the operator, together with knowledge of the anatomical region being 
irradiated, as well as patient age, sex, and physical size. For normal sized adults, the 
patient effective dose can also be obtained by multiplying the DLP by an appropriate 
body region specific k factor (E/DLP) [227, 239], and adjustments can be made to correct 
for differences in patient size [224]. The effective dose is a useful indicator of the amount 
of radiation received by the patient, and is directly related to the DLP [240]. Effective 
dose, however, is not an indicator of patient risks because it does not take into account 
patient age, sex, or which specific organs were exposed [47, 241, 242]. In this study, a 
method is described that permits the amount of radiation used to perform body CT 
examination (DLP), as well as the corresponding amount of radiation received by the 
patient (E), to be converted into the corresponding risk of carcinogenesis accounting for 
patient demographics (i.e., sex and age) and physical characteristics (i.e., size).   
6.2   Method 
6.2.1   CT Dosimetry 
The ImPACT CT Patient Dosimetry Calculator (version 1.0) was used to compute 
values of adult organ doses for specified scans [38]. The ImPACT package makes use of 
the Monte Carlo dose results from the National Radiological Protection Board‘s (now 
integrated into Health Protection Agency) report for normalized organ doses in a MIRD 
type phantom modeling a 70 kg adult [222]. The mathematical phantom is hermaphrodite 
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with a parameter z representing the position along the patient long axis, which ranges 
from -10 cm (mid thigh region) to + 94 cm (top of head).  
Five types of CT examinations were investigated (chest, abdomen, pelvis, 
abdomen/pelvis, chest/abdomen/pelvis) based on the mathematical anthropomorphic 
phantom used in the ImPACT CT Patient Dosimetry Calculator. Simulations were 
performed for each examination using eight CT scanners from four major venders. 
Information on these eight CT scanners is shown in summary form in Table 6.1. All the 
simulations were performed under the x-ray tube voltage of 120 kV and an arbitrary 
(high) tube current of 1000 mAs to minimize rounding errors.  
 
Table 6.1   The eight CT scanners investigated in this study 
Manufacturer Model 
Year of 
Introduction 
CTDIvol
a
 
(µGy/mAs) 
GE Healthcare 
LightSpeed 16 2002 99 
LightSpeed VCT 2006 95 
Philips Healthcare 
Mx8000 1998 70 
CT Secura 2000 76 
Siemens Healthcare 
Sensation 64 2004 65 
Definition AS 2008 76 
Toshiba 
Asteion Multi 1999 164 
Aquilion 16 2002 120 
a 
Measured in a 32 cm diameter body phantom at 120 kV. 
 
The amount of radiation used to perform each scan was quantified by the DLP in 
mGy-cm. In addition, each scan also has a corresponding patient effective dose using 
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ICRP 103 tissue weighting factors. Table 6.2 provides a summary of the scan lengths for 
each scan, as well as the ratios of the effective dose to the corresponding DLP. It is 
important to note that the resultant organ doses are only applicable for patients with 
physical size characteristics that are similar to the 70 kg phantom used in the ImPACT 
Patient CT Dosimetry Calculator. For a normal sized patient, the amount of radiation 
used to perform a CT examination (DLP) is directly proportional to the amount of 
radiation received by the patient (E) as defined in Table 6.2, so that both quantities can 
be used as the input term for estimating the resultant patient risk.  
 
Table 6.2   Average (± standard deviation) Effective Dose per unit Dose-Length Product 
factors (k-factors) and average (± standard deviation) relative importance of the eight 
organs investigated to the total carcinogenic detriment in body CT using ICRP 103 
weighting factors for the eight CT scanners listed in Table 6.1. 
Scan Type 
Start – End 
location
a
  
(cm) 
Scan 
Length 
(cm) 
Effective 
Dose/DLP 
(µSv/mGy-cm) 
Percentage (%) of the total 
carcinogenic detriment due to 
irradiation of the 8 organs
b
 
Chest 35 – 70 35 19.8 ± 0.6 77.5 ± 1.4 
Abdomen 20 – 44 24 18.6 ± 1.0 80.6 ± 1.0 
Pelvis 0 – 20 20 12.7 ± 0.7 86.4 ± 1.4 
Chest/Abd/Pelvis 0 – 70 70 17.3 ± 0.6 79.8 ± 0.9 
Abd/Pelvis 0 – 44 44 15.9 ± 1.0 82.8 ± 1.6 
a 
ImPACT anthropomorphic phantom z location 
b 
Red bone marrow, colon, lung, stomach, breast, liver, thyroid, and bladder 
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6.2.2   Radiation Risks 
Table 6.3 shows a list of organs for which doses can be obtained in the ImPACT 
Patient CT Dosimetry Calculator, and for which radiation risk estimates are available in 
BEIR VII [243]. The 11 organs shown Table 6.3 are termed ―sensitive organs‖ in this 
paper, and the summed risk is the sensitive organ risk. Seven of these organs (i.e., 
bladder, red bone marrow, colon, liver, lung, stomach, and thyroid) have high 
carcinogenic radiosensitivity in both males and females. Three organs have high 
carcinogenic radiosensitivity in females (i.e. breast, uterus, ovary) and one has high 
carcinogenic radiosensitivity in males (i.e., prostate).  
Table 6.3   List of radiosensitive organs in BEIR VII with their corresponding ICRP 103 
weighting factors for males and females. 
Organ 
BEIR VII Cancer Risks 
provided for: 
ICRP 103 Organ Weighting 
Factor 
(Carcinogenesis only) 
Red Bone Marrow Males and Females 0.12 
Colon Males and Females 0.12 
Lung Males and Females 0.12 
Stomach Males and Females 0.12 
Bladder Males and Females 0.04 
Liver Males and Females 0.04 
Thyroid Males and Females 0.04 
Breast Females only 0.12 
Uterus
a
 Female only Not Applicable 
Ovary
a
 Female only Not Applicable  
Prostate
a
 Male only Not Applicable 
aCalled ―sex organs‖ in this paper 
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Organ doses were converted to radiation risks using the age and gender-specific 
patient risk values provided in BEIR VII. Male risk values thus include eight ―sensitive 
organs‖, and female risk values include ten ―sensitive organs‖. The risk conversion factor 
for specified patient undergoing a given body CT examination was obtained by dividing 
the total cancer risk from ―sensitive organs‖ by the computed DLP for each CT 
examination, as well as the corresponding effective dose.  
In addition to the eleven organs listed in Table 6.3, BEIR VII also provides a 
category known as ―other‖ that refers to all other radiation induced cancers that are not 
otherwise explicitly listed. Eight of the organs listed in Table 6.3 have explicit ICRP 
organ weighting factors [47] relating to carcinogenesis, and the remaining three do not. 
Organs with no explicit ICRP carcinogenesis weighting factor are called ―sex organs‖ 
and relate to the prostate in males, and the sum of the ovaries and uterus in females.  
 
6.2.3   Patient Size Correction Factors 
At a constant radiation intensity used to perform a given CT examination, organ 
doses are always reduced with increasing patient size, and vice versa. As the patient size 
increases, there is an increased attenuation of the x-ray beam, and radiation doses are 
always reduced [238]. For a given x-ray output, the key determinant of organ doses is 
therefore the physical size (i.e., mass) of the patient being irradiated. Patient mass in a CT 
slice may be readily obtained from CT images that provide both the cross sectional area 
and the corresponding average Hounsfield Unit (HU) [244]. At high photon energies 
encountered in CT, most interactions are Compton scatter which is directly proportional 
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to electron density, which in turn is proportional to patient physical density [193].  
 Once the patient mass is available from a CT image, this patient can be modeled 
as an equivalent cylinder of water. This approach permits the use relative doses as a 
function of water cylinder diameter to be used to estimate how effective doses vary with 
patient size [113]. The relative dose (Rsize) is defined as the ratio of the dose in a water 
cylinder that has a mass equivalent to a patient of a specified size divided by the 
corresponding dose in a water cylinder that has a mass equivalent to the ImPACT 
anthropomorphic phantom (i.e., normal sized adult). The size metrics used in this study 
relate to patient weight W (i.e., RW) and the body Antero-Posterior (AP) thickness (i.e., 
RAP). Relative doses in cylindrical water phantoms of varying sizes for representative CT 
spectra ranging from 80 to 140 kV are available in the scientific literature [224].  
The ImPACT phantom has a nominal weight (W) of 70 kg, and an antero-
posterior (AP) dimension in the chest of 23.4 cm, and in the abdomen of 22 cm [244, 
245]. We used data in the scientific literature to generate both weight based adult patient 
size correction factors RW as well as AP adult size correction factors RAP that can be 
applied for adult chest [245] and abdomen/pelvis [244, 246] CT examinations. Since 
radiation risk is directly proportional to organ doses, RW and RAP factors can be used to 
adjust the radiation risk obtained for a 70 kg patient to be scaled to other adult sizes.  
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6.3   Results 
6.3.1   “Sensitive Organ” Carcinogenic Risk  
Figure 6.1 shows the cancer incidence risks to ―sensitive organs‖ for chest, 
abdomen, and pelvis CT scans, and Figure 6.2 shows the corresponding data for 
Chest/Abdomen/Pelvis (CAP) and Abdomen/Pelvis (AP) CT scans. Each graph in 
Figures 6.1 and 6.2 shows the risk of cancer induction for the sensitive organs listed in 
Table 6.3 as a function of patient age for both males and females for a standard sized (70 
kg) patient. For each type of CT scan, the amount of radiation used to perform the CT 
scan is quantified in terms of the DLP value measured in a 32 cm diameter (body) CT 
dosimetry phantom. Since each scan provides a corresponding patient effective dose, 
radiation risk from sensitive organs can also be normalized by the patient effective dose 
in mSv. For each CT examination, each datum is the average value obtained for 
calculations performed on the eight CT scanners listed in Table 6.2, and the error bars 
show the computed values of the corresponding standard deviation. The maximum value 
of coefficient of variation for the eight scanners investigated was 3%. 
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Figure 6.1   Normalized sensitive organ risks in chest, abdomen and pelvis CT 
examinations per 100,000 patients. Figures in the left column have been normalized by 
the DLP (mGy-cm) and Figures in the right column normalized by the corresponding 
patient effective dose (mSv).  
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Figure 6.2   Normalized sensitive organ risks in Chest/Abdomen/Pelvis and 
Abdomen/Pelvis CT examinations per 100,000 patients. Figures in the left column have 
been normalized by the DLP (mGy-cm) and Figures in the right column normalized by 
the corresponding patient effective dose (mSv).  
 
The highest ―sensitive organ‖ risks per DLP are associated with chest and CAP 
examinations, and the lowest normalized ―sensitive organ‖ risks are associated with 
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abdominal examinations. For CT examinations that include the chest, female ―sensitive 
organ‖ risks are markedly higher than those for males, whereas for examinations that 
include the pelvis, ―sensitive organ‖ risks in males are slightly higher than those in 
females. In abdominal CT scans, ―sensitive organ‖ risks in males and female patients are 
essentially identical. As expected, the there is a marked reduction in ―sensitive organ‖ 
radiation risks with increase in patient age. For abdominal CT scans, for example, 
increasing the patient age from 20 to 80 resulted in a reduction in patient ―sensitive 
organ‖ risks of nearly a factor of five. 
 
6.3.2   Relative Organ Sensitivity 
Figure 6.3 shows the contributions of each of the eight male ―sensitive organs‖ to 
the total cancer risk for males and Figure 6.4 shows the corresponding contribution of 
each of ten female ―sensitive organs‖ to the total cancer risk for females. Data shown in 
Figure 6.2 and 6.3 have been averaged over eight scanners (Table 6.2), and error bars 
show the corresponding standard deviations.   
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Figure 6.3   Relative contributions of eight male organs to the total sensitive organ 
cancer risk for the five types of body CT examinations investigated.  
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Figure 6.4   Relative contributions of ten female organs to the total sensitive organ 
cancer risk for the five types of body CT examinations investigated.  
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Table 6.4 shows the relative contribution of the sex organs, namely prostate for 
males and uterus plus ovaries for females, to the total sensitive organ cancer risks from 
selected CT examinations. Data in Table 6.4 can be used to estimate the radiation risks 
from organs with a carcinogenic weighting factor (Table 6.3), and the latter can be used 
to estimate the total cancer risk (see Discussion).  
 
Table 6.4   Average contribution (%) of sex organs (prostate for males; uterus and 
ovaries for females) to the total sensitive organ cancer risk from selected body CT 
examinations. 
Patient 
Age 
Chest Abdomen Pelvis 
Male Female Male Female Male Female 
20 0.0 0.1 0.8 4.6 19 25 
30 0.0 0.1 0.8 4.5 19 24 
40 0.0 0.1 0.8 4.3 19 23 
50 0.0 0.1 0.8 3.8 19 20 
60 0.0 0.1 0.8 3.2 17 17 
70 0.0 0.1 0.6 2.6 13 14 
80 0.0 0.0 0.4 2.1 9.7 12 
 
For males, the lung cancer risks are dominant for chest CT scans, colon cancer 
risks are dominant for abdomen and pelvis examinations, and bladder cancer risks are 
dominant for pelvis examinations. For females, lung cancer risks are dominant for chest 
CT examinations, but with breast cancer also important for younger patients. Bladder 
cancer risks are dominant for female pelvis examinations.  
Organs that are of moderate importance include the red bone marrow for the 
130 
 
induction of leukemia for all body CT examinations, as well as stomach cancer for 
abdominal examinations in both males and females. In males the prostate contributes up 
to 20% of the total cancer risk for pelvis CT examinations, and in females, the ovaries 
can exhibit a similar importance in pelvis examinations. Radiation risks of liver cancer 
are generally low, but which exceed 10% of the total risk for males undergoing 
abdominal CT scans. Thyroid cancer risks are generally very low, reflecting the fact that 
this organ is not directly and wholly irradiated in any body CT examination. 
 
6.3.3   Other Organ Risks 
Table 6.5 shows the relative importance of the cancers in the ―other organ‖ 
category associated with uniform whole body irradiation according to data presented in 
BERI VII. Data provided in Table 6.5 permit the total cancer risk to be estimated for 
examinations that can be approximated to uniform whole body examinations.  
Table 6.5   Relative importance of the ―other organ‖ category provided in BEIR VII. 
Age 
Percentage of cancer risk from “other organs” 
for uniform whole body irradiation in: 
Male Female 
20 32 20 
30 29 19 
40 27 20 
50 24 20 
60 20 19 
70 17 17 
80 13 14 
Average (± standard deviation) 23 ± 6.7 18 ± 2.3 
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A 50 year old female undergoing a Chest/Abdomen/Pelvis scan is likely to have a 
total cancer induction risk that is about 25% higher than the sensitive organ risk value 
shown in Figure 6.2, when these are taken as being equivalent to uniform whole body 
irradiation. Averaging over all adult ages and both sexes, the average cancer risk is thus ~ 
26% higher than the ―sensitive organ‖ cancer risk for CAP examinations.   
 
6.3.4   Patient Size 
Figure 6.5 shows dose correction factors (RW and RAP) for adults undergoing 
chest and Abdominal/Pelvic CT examinations. Patient risk is directly proportional to 
organ dose and the data shown in Figure 6.5 estimate how organ doses will change with 
patient size for fixed incident radiation intensity (i.e., CTDIvol and DLP). Correction 
factors shown in Figure 6.5 may therefore be applied directly to adjust risk estimate 
generated for a normal sized adult to obtain the corresponding risk estimate in smaller or 
larger adult patients. Body CT doses and radiation risks in 80 kg adults, the current 
reported median adult weight in the US, are about 10% lower than those in 70 kg patients 
[247].  
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Figure 6.5   Relative doses as a function of patient weight W (upper) and as a function of 
patient Antero-Posterior dimension AP (lower).  
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6.4   Discussion 
Subtracting the risk attributed to the ―sex organs‖ (Table 6.4) from the sensitive 
organ cancer risks shown in Figures 6.1 and 6.2 yields the risk from the eight organs 
listed in Table 6.1 that have individual ICRP tissue weighting factors [47]. Knowledge of 
the risk from these eight organs permits an estimate to be obtained of the total cancer risk 
by analyzing the relative importance of these organs when computing total effective 
doses after any genetic component has been excluded. The last column of Table 6.2 
shows the relative importance of these eight organs to the total carcinogenic detriment 
which were generated from effective doses computed in the ImPACT spreadsheet for the 
eight CT scanners listed in Table 6.1. Data in Table 6.2, together with data in Table 6.4, 
permit a crude estimate of the total cancer risk to be obtained that takes into account both 
―sensitive organs‖ and the ―other category‖.  
Consider a 70 kg 50 year old female who has a chest CT scan with a DLP of 450 
mGy-cm (CTDIvol of 15 mGy and scan length of 30 cm). Using data shown in Figure 
6.1, the ―sensitive organ‖ cancer induction risk for this patient would be 68 per 100,000 
examinations. Data in Table 6.4 show that for females the ―sex organ‖ contribution to 
this risk is negligible (0.1%), and data in Table 6.2 show that the eight listed organs 
account for 78% of the total cancer detriment. In this example, the patient cancer 
―sensitive organ‖ cancer risk of 68 per 100,000 should be increased to 87 per 100,000 
(i.e., 0.089%) to account for contributions from the ―other organ‖ category. It is 
important to use data shown in Table 6.2 as a guide, and not an exact algorithm, because 
the ICRP tissue weighting factors used for computing effective doses are averaged over 
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age and weight, and account for detrminent attributed to both cancer and genetic effects 
[241, 242].  
Patient risks in CT imaging clearly may be obtained directly from DLP data 
without computing the corresponding effective dose. However, there are benefits to 
retaining the effective dose metric which provides a practical quantitative indicator as the 
amount of radiation a patient received by patient [48, 240]. The effective dose in a CT 
examination can be compared with effective dose from other examinations, and provides 
a valuable context when compared with benchmark effective doses such as natural 
background [234, 236]. When effective doses are converted into risk values as depicted 
in Figures 6.1 and 6.2, the specific value of the weighting factor for any organ does not 
affect the result patient risk. This can be illustrated by considering a radiological 
examination that exposes one single organ with an arbitrary tissue weighting factor w, 
and assume this organ receives dose D resulting in a cancer risk R. The patient effective 
dose would be (D x w), and the risk per effective dose would be R/(D x w) so that the 
risk from effective dose (D x w) is R, and is always independent of tissue weighing 
factor.  
It is important to note that the methodology developed in this paper is based on 
adult patients [38, 222]. Children cannot be assumed to be simply small adults, because 
the relative proportions of different organs and tissues change with age [248]. For 
example, the size of a newborn head relative to the body changes dramatically with 
increasing age. In addition, the relative importance of scatter radiation will be much 
higher in infants than in adult because of reduced distances as well as reduction of 
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attenuation of intervening tissues [249]. Specifically, patient size correction factors given 
in Figure 6.5 should not be used to estimate either effective doses or radiation risks to 
any pediatric patient undergoing CT examinations. Risks to pediatric patients undergoing 
CT examinations would need to explicitly taken into account the fact at constant CT 
radiation intensity (DLP), effective doses increase sharply with decreasing age [227], and 
that at constant effective dose, radiation risks also increase sharply with decreasing age 
[243].  
At high radiation doses, there is little disagreement about the carcinogenic effects 
of ionizing radiation. As dose levels are progressively reduced, however, the amount of 
empirical data on the harmful effects of x-ray exposures progressively diminishes. With 
less empirical data, that is also subject to a range of possible interpretation, controversies 
regarding harmful effects of radiation increase [250]. BEIR VII, for example, provides 
risk estimates for organ doses of 100 mGy that implicitly serve to alert users that 
extrapolating risks to 10 or 1 mGy is associated with large uncertainties [243]. Major 
scientific bodies, including the Committee on the Biological Effects of Ionizing Radiation 
[243], International Committee on Radiological Protection [47], and the United Nations 
Scientific Committee on the Effects of Atomic Radiation [251] all assume that for 
radiation protection purposes,  radiation risks exist at low doses. Accordingly, it is 
reasonable to assume that the quantitative risk estimates derived in this study are the most 
accurate approximations currently available, albeit associated with large uncertainties 
[243, 250]. 
To fully appreciate the significance of any medical radiation exposure, nominal 
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cancer risk of the type reported in this study would need to be converted into a measure 
of detriment [252, 253]. Patient detriment should take into account the relative 
importance of cancer incidence and cancer mortality, as well as issues that relate to 
quality of life [47]. Of paramount importance, however, is the well known fact that there 
is a relatively long latent period associated with radiation induced cancer [254]. For 
leukemia, latent periods are generally considered to be of the order of a few years, 
whereas for many solid tumors, latent periods are measured in decades. A 50 year old 
male having a chest CT examination with an effective dose of 10 mSv has a nominal 
cancer risk of about 0.04%. However, if this individual‘s life expectancy were only one 
to two years, because of some underlying medical condition, it is likely that his/her true 
radiation induced detriment would be taken as being zero.  
Risk conversion factors can be used to estimate the potential risk for cancer 
induction for any individual patient at body CT, and thereby provide a rational basis for 
weighing expected benefits against potential risks [220, 255]. A recent study has shown 
that in cardiac CT, individualized median cancer induction risks in sensitive organs for 
males and females of 0.065% and 0.176%, respectively [215]. Awareness of radiation 
risks also encourages practitioners to take appropriate steps to keep all patient exposures 
as low as reasonably achievable (ALARA), particular in MDCT imaging [203]. 
Furthermore, the fact that radiation risks in CT imaging are finite promotes the 
development of protocols and technology that could reduce patient exposures without 
adversely impacting on diagnostic performance [217, 256, 257].  
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6.5   Conclusion 
The medical imaging community requires an estimate of individual patient 
radiation-induced carcinogenic risks in order to identify that patient benefits exceed (any) 
risk during indicated examinations. The amount of radiation used to perform body CT 
examinations (DLP) is always available to medical staff. This paper describes a method 
for estimating organ doses and the corresponding organ risks for normal sized patients 
based on the DLP values used to perform the CT examination. Correction factors based 
on patient weight or AP dimension are also provided which permit a nominal patient risk 
to be obtained for different-sized adults undergoing any type of body CT examination. 
Computation of the corresponding radiation risks thus explicitly take into account the 
amount of radiation used to perform the CT examination, the body region exposed, as 
well as patient physical characteristics. These individualized radiation risks are the best 
currently achievable estimates, and can be used to educate the medical imaging 
community about adult risks associated with body CT examinations. This knowledge is 
essential for justifying body CT examinations so that exposed patients receive a net 
benefit. 
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CHAPTER 7   PHOTON ENERGY, RADIATION DOSE AND IMAGE QUALITY IN 
INTERVENTIONAL RADIOLOGY 
7.1   Introduction 
One of the most challenging dilemmas in diagnostic radiology is to obtain a 
desired image quality while keeping the radiation doses to a patient as low as reasonably 
achievable (ALARA) [258, 259]. It is well known that increasing the x-ray tube voltage 
can reduce the skin entrance dose and decrease the image contrast at the same time. 
Imaging with lower tube voltage improves image contrast, but may also increase the 
entrance skin dose and patient dose [260, 261]. However, there have been few thorough 
studies investigating the relationship between the radiation dose and x-ray tube voltage 
under fixed image quality.  
The purpose of the presented study is to investigate the skin dose and energy 
imparted under different incident photon energy levels with constant image quality. 
Based on a simple geometry setting, we simulated cases by running Monte Carlo 
simulations on the Clemson Palmetto Cluster [262] with small relative errors. The impact 
of incident photon energy on the skin dose as well as total energy imparted was analyzed 
under different imaging scenarios, according to whether grids are utilized. 
7.2   Method 
7.2.1   Simulation Geometry 
Figure 7.1 shows a schematic of the geometry for simulation cases used in this 
study. The irradiation geometry consisted of a monoenergetic x-ray source, a water 
cylinder with 15 cm depth along the x-ray beam, and an imaging plane 5 cm away from 
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the water phantom. To create the imaging contrast, a 0.001 cm thick and 2 cm wide slab 
filled with iodine was placed at the center of the water phantom. The human epidermis 
skin layer was represented by a thin water layer with thickness of 0.1 cm within the 
surface of the water cylinder which is close to the x-ray source. 
 
Figure 7.1   Schematic of the simulation geometry used in this study 
The depth of water phantom was chosen to represent an average 5-year-old child. 
The average weight of 5-year-olds is ~18.5 kg (41.8 lbs for boys, 39.6 lbs for girls), and 
this weight corresponds to a water cylinder phantom with diameter of ~15 cm using 
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methods in previously published research [263]. The 5-year-old patient phantom in 
PCXMC software also has the AP dimension of 15 cm. 
The x-ray source was modeled as a surface source which projects parallel x-ray 
beams perpendicular to the surface of the water phantom. X-rays were confined to just 
cover the geometry. Simulations were performed using monoenergetic x-rays with 
energies ranging from 35 keV to 80 keV.  
Monte Carlo simulations were performed using MCNP5 codes (Los Alamos 
National Laboratory) [264]. The track length cell energy deposition tallies (F6 tallies) in 
MCNP were used to obtain the radiation dose to the skin layer, the iodine block and the 
water cube separately. The point flux detector tallies (F5 tallies) were used to obtain the 
photon fluences on the image plane. The flux image radiography tallies FIR5 were used 
on the imaging plane with 0.2 cm x 0.2 cm sized grids. One million photons were used 
for each of the simulations, which were performed on the Clemson Palmetto Cluster 
distributed computing system (1,978 nodes and 20,728 cores) [262]. 
7.2.2   Image Quality 
The image quality quantities investigated in this study include contrast, noise, and 
contrast-to-noise ratio (CNR).  
Contrast (C) was defined as the difference between the photon fluence value 
within the unit area and background fluence normalized by the total photon fluence 
(including scatter) in the background.  
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where ΦP1 and ΦP2 are the primary photon fluences (number of photons per unit area) in 
the background and region of interest correspondingly, and ΦS1 is the scattered photon 
fluence in the background. 
Noise was defined as energy weighted quantum noise. Increasing the number of 
incident photons will cause the decrease of relative noise; when scatter exists, the relative 
noise will increase.
 
 
              
 (7.2)
 
 
where (E)S is the probability density function of S with energy as the variable, and EP1 
and ES1 are the energy levels of the primary and scattered photons in the background. 
Contrast-to-noise ratio (CNR) was calculated as the ratio of the contrast and 
noise.  
 
        (7.3) 
 
 
For the different imaging scenarios investigated, the proportions of primary 
photons and scattered photons were modulated. For scenario 1) without grids, all of the 
scattered photons and primary photons were taken account into the calculation for the 
image quality. For scenario 2) with 8:1 grids, all the image quality calculations were 
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performed assuming that 10% of the scattered photons and 70% of the primary photons 
which penetrated the geometry reached the imaging plane.  
7.2.3   Sampling Points for Calculations 
As shown in Figure 7.2, in order to calculate Contrast, Noise, and CNR with the 
simulation results, the average reading from y = -2 and y = 2 (cm) along the center axis of 
the imaging plane was used as background (ΦP1, ΦS1); reading from y=0 (cm) was used 
as the signal (ΦP2). The background sampling points were chosen because they are 1 cm 
from the signal area and not likely to be in the line spread function region (which is 
affected by the scattering from the signal area). Notice here that the photon flux at a point 
is in fact the average flux to a 0.2 cm x 0.2 cm grid with the point at its center on the 
imaging plane. The choice of the size of the sampling grids may have slight influence on 
the accuracy of the flux result. 
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Figure 7.2   Illustration of sampling points on the imaging plane 
The energy fluence for the primary photons (p) was obtained by the calculating 
the product of the primary photon fluence and the incident photon energy. The energy 
fluence for the scattered photons (s) was calculated as product of scattered photon fluence 
and the energy levels of scattered Compton photons. 
7.2.4   Monte Carlo Validation 
To validate the Monte Carlo simulation results, the analytically calculated surface 
dose results were compared with MCNP simulation results generated using a simplified 
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model shown in Figure 7.3. The simulation geometry consists of a water cube with 20 
cm on each side, and a parallel beam x-ray source irradiating monoenergetic photons with 
energies ranging from 35 to 80 keV. Doses to the skin layer at different incident photon 
energies were obtained to compare with the surface dose results from theoretical 
calculations. 
 
Figure 7.3   Schematic of the simulation geometry used for Monte Carlo validation. 
 
In the analytical calculations, surface dose (DS) was defined as: 
A
A
Bh
A
ABh
At
BthA
M
E
D
abab
ab
s
s
s
''
'
')'(
0
101
01













 ,        (7.4) 
145 
 
where Φ0 is the incident photon fluence, A‘ is the surface area expressed in pixels, and A 
is the surface area expressed in cm
2
. In this study, we assumed 2 pixels per mm, thus 
A‘/A=400. t‘ is the thickness of the surface layer; hv is the energy of an incident photon; 
µab/ρ is the mass absorption coefficient of water; B is the backscatter factor, which was 
set to be a fixed value of 1.3 (for diagnostic radiology) [265] in the following calculations. 
In the analytical calculations, energy imparted (Eab) was defined as: 
 
,          (7.5) 
where A‘ is the surface area of the geometry represented by the corresponding number of 
pixels.  
This estimation was made under the assumption that the mass absorption 
coefficient difference between the two materials is small, and thus the extra energy 
absorbed by the small contrast block is small and can be ignored for this case. Thus, the 
absorbed energy is approximately two thirds of the total incident energy. 
7.3   Results and Discussion 
7.3.1   Energy Imparted and Skin Dose under Fixed CNR 
Figure 7.4 shows the relative values of energy imparted (REI) and skin dose 
(RSD) as functions of the incident photon energy under fixed CNR value of 5. Figure 7.5 
shows the REI and RSD results from theoretical calculations with scatter-to-primary ratio 
of 1:1. The values of energy imparted and skin dose were normalized by their 
corresponding values at 80 keV, so that the relative values of both quantities at 80 keV 
were unity. 
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Figure 7.4   REI and RSD results from MCNP simulations under fixed CNR. 
 
Figure 7.5   REI and RSD results from theoretical calculations (s/p = 1) under fixed CNR. 
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As shown in Figure 7.4, under fixed CNR=5, the lowest RSD was reached at 40 
keV (14% of that for 80 keV with MCNP results; 13% of that for 80 keV with analytical 
calculations). For RSD, under fixed CNR=5, doubling the incident photon energy from 
40 keV to 80 keV increases by ~710% according to simulation results, and by ~770% 
according to theoretical calculations. Doubling the incident photon energy from 35 keV 
to 70 keV increased RSD by ~340% in simulation and only by ~150% in theoretical 
calculations; Increasing the incident photon energy from 40 keV to 60 keV has doubling 
effect on the skin dose.  
Based on MCNP simulation results, REI increases monotonically with the 
incident photon energy with deeper increasing slopes than RSD. However, with 
theoretical results, REI reaches lowest at 40 keV. From the MCNP simulation results, 
under fixed CNR=5, total energy imparted at 80 keV is ~10 times of that at 40 keV; while 
with the theoretical calculations, the total energy imparted at 80 keV is ~21 times of that 
at 40 keV. This phenomenon could have been caused by the scattering photon energy 
spectrum assumed in the theoretical calculations, where the scattered photons are 
assumed from the first scattering interaction with energies very close to the incident 
photon energy, and higher than the average scattered photon energy shown in the 
simulation results. Thus, the energy imparted values are overestimated in the theoretical 
calculations. 
The k-edge (33.2 keV) effect was prevailing at 35 keV and the absorbed skin dose 
was estimated as ~1.1 times of the value for 40 keV based on MCNP results and ~2.4 
times of the value for 40 keV in the analytical calculation. The results were found out to 
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be very sensitive to the choice of the attenuation and absorption coefficients used for 35 
keV. The theoretical calculations mentioned in this report used the interpolation method. 
The accuracy of the attenuation coefficient could be causing the difference between the 
simulation and theoretical result trends. This difference may have also been caused by the 
backscatter factors and the scattered photon spectra difference. Further investigation is 
needed to examine these impact factors. 
7.3.2   Energy Imparted and Skin Dose under Fixed Output Photon Energy Fluence 
Figure 7.6 and Figure 7.7 show the relative skin dose (RSD) and relative total 
energy imparted (REI) under fixed energy fluence at the imaging plane as functions of 
the incident photon energy (i.e., ΦP1* EP1+ ΦS1* ES1 = Constant, the constant was set to 
be 1 in the cases below for calculations). Skin doses and total energy imparted were 
normalized to their corresponding values at 40 keV. The average reading from y = - 2 and 
y = 2 at the center axis of the imaging plane was used as background (ΦP1, ΦS1); reading 
from y = 0 was used as the signal (ΦP2). 
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Figure 7.6   REI and RSD results from MCNP simulations under fixed output energy 
fluence. 
 
Figure 7.7   REI and RSD results from theoretical calculations (s/p = 1) under fixed 
output energy fluence. 
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REI and RSD under fixed output photon energy fluence from MCNP simulation 
results have the same trends as functions of the incident photon energy as those from 
theoretical calculations. Doubling the incident photon energy from 40 keV to 80 keV 
decreases skin dose by ~90% according to simulation results, and by ~89% according to 
theoretical calculations. Doubling incident photon energy from 35 keV to 70 keV 
decreases skin dose by ~95% with MCNP simulation results, and by ~96% with 
theoretical results. Under fixed output energy fluence, total energy imparted at 80 keV is 
~15% of that at 40 keV for MCNP results; while the total energy imparted at 80 keV is 
~28% of that at 40 keV with the theoretical calculations. From the MCNP simulation 
results, under fixed output energy fluence, total energy imparted at 70 keV is 9% of that 
at 35 keV; while with the theoretical calculations, the total energy imparted at 70 keV is 
~15% of that at 35 keV. 
 
7.3.3   Output Photon Energy Spectra 
In order to investigate the difference between the MCNP simulations and the 
assumptions made in the theoretical calculations, we looked in the energy distribution of 
the scattered photon spectra of the MCNP simulations and the analytical assumption. The 
output scattered photon spectra from MCNP results and analytical calculations are shown 
in Figure 7.8 and Table 7.1, respectively. 
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Figure 7.8   Output scattered photon spectra from MCNP simulation results (see 
coordinate illustration in Figure 7.2). 
 
Table 7.1   Output Scattered Photon Spectra assumed in Analytical Calculations 
Incident Photon Energy  
(keV) 
Scattered Photon Energy (keV) 
20 degree (1/3) 40 degree (1/3) 60 degree (1/3) 
35 0.0349 0.0344 0.0338 
40 0.0398 0.0393 0.0385 
50 0.0497 0.0489 0.0477 
60 0.0596 0.0584 0.0567 
70 0.0694 0.0678 0.0655 
80 0.0793 0.0772 0.0742 
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For analytical calculations, assumptions were made that the scatter spectrum was 
composed of a third of 20°, a third of 40° and a third of 60° scattered photons, with 
energies calculated using the following equations: 
    (7.6) 
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where Es is the energy of the scattered photons with the corresponding scattering angle. 
As shown in Table 7.1, the assumed spectra in theoretical calculations are all within 
the first 10 keV energy bin from the incident photon energy, and the energies of the 
scattered photons are all within 7% difference from the incident photon energy. However, 
in the MCNP output scatter spectra, there are a substantial amount of scattered photons 
with an energy level that is more than 10 keV from the initial energy. This may be caused 
by the fact that MC simulations took into account multiple scattering events for each 
photon and thus lowered the average energy of the output scattered photons.  
7.3.4   Scattered to Primary Ratios from MCNP Results  
Figure 7.9 shows the s/p ratios imaging plane at the center of the contrast area (y 
= 0 cm) as well as the flanking location (y = -2 cm and 2 cm) under different incident 
photon energies. The average s/p ratio is ~1.17 for y = 0, and ~1.06 for y = -2 or 2 cm. 
Increasing the incident photon energy from 35 keV to 80 keV decreased the s/p ratio by 
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28% and 17% for y = 0 and y = -2 or 2, respectively. This is another factor contributing 
to the difference between simulation results and the analytical calculations, where s/p 
ratio of 1:1 was assumed. 
 
Figure 7.9   MCNP results of output scatter to primary photon ratio at different incident 
photon energies. 
 
7.3.4   Impact of Grids 
Adding grids in front of the imaging plane will increase the image quality by 
causing a different transmission rate between primary and scattered photons, while at the 
same time increasing the incident photon numbers and thus increasing patient doses.  
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From previously published research [266], at 60 keV, for linear 8:1 grids, primary 
transmission rate (TP) is ~65% and scatter transmission rate (TS) is ~ 10%. In the 
following calculations, we took TP = 70% and TS = 10% as the typical transmission rates 
in all the calculations. 
Figure 7.10 shows the impact of grids on the results under a fixed CNR value of 
5. The values are normalized by the corresponding energy imparted or skin dose value 
without grids at 80 keV. Figure 7.11 shows the impact of grids on the results under fixed 
output energy fluence at imaging plane. The values are normalized by the corresponding 
energy imparted or skin dose value without grids at 40 keV. 
 
Figure 7.10   MCNP results of REI and RSD under fixed CNR with or without grids. 
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Figure 7.11   MCNP results of REI and RSD under fixed output energy fluence with or 
without grids.  
 
The imaginary grids were assumed to permit 70% of the primary photons and 10% 
of the scattered photons to transmit. As shown in Figure 7.10 and Figure 7.11, adding 
these grids didn‘t affect the shape of the curves, which means it didn‘t change the 
variation of the skin dose or the total energy imparted values as functions of the incident 
photon energy. Under fixed CNR, adding the grids decreased skin dose and total energy 
imparted by ~21% on average. Under fixed energy fluence at the receptor, adding the 
grids increased skin dose and total energy imparted by ~64% on average. 
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7.4   Conclusion 
In summary, the choice of x-ray tube voltage in interventional radiology 
examinations affects both image quality and patient doses. Skin dose and energy 
imparted are different radiation quantities that need to be taken into consideration, 
depending on specific procedures. In order to keep radiation doses to patients as low as 
reasonably achievable (ALARA), the amount of x-ray input used should be no more than 
what is required to achieve a satisfactory image quality for effective diagnosis. 
Our results showed that under a fixed image quality represented by CNR, energy 
imparted increased with photon energy, while skin dose was not a monotonic function of 
photon energy and reached its minimum at ~ 40 keV. Under fixed output energy fluence, 
both skin dose and energy imparted decrease monotonically with the incident photon 
energy, and the skin dose is more sensitive to changes in photon energy than total energy 
imparted. These results demonstrated the benefit of using Monte Carlo methods to 
optimize the x-ray tube voltage for a relatively low dose under the desired image quality 
for a specific patient undergoing a certain type of diagnostic imaging. 
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CHAPTER 8   IODINATED CONTRAST AGENT CAUSED PATIENT DOSE 
INCREASE IN RADIOGRAPHY 
8.1   Introduction 
Iodinated contrast media are frequently used in radiological examinations to 
visualize anatomical features that are normally invisible on conventional radiographic 
images [267, 268]. Iodine is a high atomic number material (Z = 53) with inner k-shell 
electrons that have a relatively high binding energy of 33 keV. For x-ray photon energies 
which are above this k-edge energy, iodine will absorb many more x-rays than soft 
tissues. A small amount of iodine in a blood vessel or an organ results in a dramatic 
increase in x-ray attenuation (relative to water) permitting the otherwise invisible 
vasculature to be visualized [269].  
With the increase of absorbed x-rays, radiation doses in iodine charged tissues 
and organs also increases. This phenomenon has been studied and proposed as a 
theoretical basis for contrast-enhanced radiotherapy (CERT) procedures [270-272]. For 
the last three decades, techniques based on this concept have been developed, through 
both theoretical and experimental studies using dosimetry measurements in phantoms and 
animal models, as well as Monte Carlo simulations [273-277]. 
Concerns have also been raised regarding the use of iodinated contrast in 
diagnostic radiological examinations. Recent studies [278, 279] suggest that the increase 
in x-ray absorption by iodine can result in relatively high radiation doses to the patient 
regions being directly irradiated that contain iodine. One report has indicated that kidney 
doses can be 74% higher in CT scans when performed with iodinated contrast [278]. In 
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these reports, however, the total energy that is deposited in the patient was not taken into 
account, and it is also not clear how radiation doses change for organs and tissues that are 
adjacent or behind the organs taking up iodine.  
While measuring radiation doses with dosimeters in vivo and in vitro is usually 
cumbersome and, under some circumstances, unrealistic, Monte Carlo methods have 
been used widely in medical physics to simulate radiation doses [30, 280]. There are 
several Monte Carlo software packages developed for simulating radiation transport 
through different media, among which MCNP5/MCNPX [264], EGS4/EGSnrc [281], 
GEANT4 [282] are considered as reference codes. 
In this study, we used models based on the MCNP5/MCNPX platform to address 
the issues of not only what the level of increased radiation dose to an organ containing 
iodine is, but also how the pattern of energy deposition changes, as well as the changes of 
the total amount of energy absorption by the phantom (or patient) being irradiated. In 
order to validate our Monte Carlo models, we also compared results from a designed 
simple Monte Carlo simulation case with its corresponding analytical solutions. 
 
8.2   Method 
8.2.1   Simulation Phantoms 
Figure 8.1A shows a schematic of the phantom used in this study, which consists 
of a 28 cm diameter water sphere containing a smaller sphere at the phantom isocenter 
that holds iodine and water mixture solution (contrast sphere). The 28 cm diameter was 
chosen to represent a typical adult abdomen region with an equivalent depth of water 
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[263]. Figure 8.1B shows the same phantom as depicted in Figure 8.1A, except that the 
content in the contrast sphere at the isocenter has been replaced by water. Two variables 
were investigated as follows:  
1). Diameter of the contrast sphere, which was allowed to take on values of 0.5 cm, 4 
cm, and 16 cm.  
2). Iodine concentration in the contrast sphere, which was allowed to take on values 
of 1 mg/ml, 10 mg/ml, and 100 mg/ml.  
 
Figure 8.1   (A) Phantom with an Iodine Sphere (yellow) located at the phantom center 
containing iodinated contrast material; (B) The same phantom as shown in A, but with no 
iodinated contrast material within the ―Iodine Sphere‖ region. 
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The mass attenuation coefficients of the iodine and water mixture inside the 
contrast sphere (µM/ρM) with different iodine concentrations were calculated using [283] 
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where φW and φI are the mass fractions of the water and iodine in the contrast medium, 
respectively, and μW and μI are the linear attenuation coefficients of water and iodine, 
respectively. Table 8.1 shows the Hounsfield Unit (HU) values of the contrast medium, 
which are given by [284] 
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where μM is the linear attenuation coefficient of the iodine-water mixture. 
 
Table 8.1   Hounsfield Unit (HUM) of the iodine and water mixture solution inside the 
Iodine Sphere with different iodine concentrations. 
Iodine concentration 
(mg/ml) 
HUM 
(under incident photon energy =  ) 
40 keV 60 keV 80 keV 100 keV 150 keV 
1 16.7 7.47 3.88 2.31 0.940 
10 167 74.7 38.8 23.1 9.40 
100 1671 747 388 231 94.0 
 
Three fictitious spheres were also simulated, each with a diameter of 1 cm and 
located directly in front of the contrast sphere, to its side and to its rear. The closest 
distance from the edge of the contrast sphere to these fictitious water spheres was kept 
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constant at 1 cm, and independent of contrast sphere diameter. The phantom isocenter 
was located at a distance of 100 cm from an x-ray source. The x-ray source consisted of 
mono-energetic photons. 
8.2.2   Relative Energy Imparted 
We obtained values of relative energy imparted, Erel, as the ratio of the energy 
imparted in a defined region in the phantom shown in Figure 8.1A with the 
corresponding value of energy imparted to the same region using the phantom depicted in 
Figure 8.1B. The following volumes were considered as specific regions of interest: 
1). The sphere containing the iodine at the phantom isocenter, which was termed as 
Erel(Iodine). 
2). Three fictitious water spheres located in front of the contrast sphere, Erel(Front), to 
the side of the contrast sphere, Erel(Side), and at the rear of the contrast sphere 
Erel(Rear).  
3). The whole phantom shown in Figures 8.1A and 8.1B, and termed Erel(Phantom).  
We performed a detailed analysis with mono-energetic incident photons of 60 
keV for simulations at three contrast sphere diameter values and four investigated 
solutions (three mixtures with different Iodine concentrations and one solution with water 
only). These computations involved a total of 12 simulations, with five values of relative 
energy imparted obtained in each simulation with iodine at the isocenter of the phantom 
compared with the corresponding simulation with water at the isocenter. Computations 
were also obtained at five levels of incident photon energy (35 keV, 45 keV, 75 keV, 100 
keV, and 150 keV) for the selected diameters of contrast sphere at an Iodine 
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concentration of 100 mg/ml. Computed data points in all graphs were fitted to spline 
curves for ease of viewing. 
 
8.2.3   Monte Carlo Model 
Monte Carlo techniques have become widely used in medical physics dosimetry 
applications because they can provide accurate predictions of the absorbed dose 
distributions in diagnostic and therapeutic radiological procedures. In this project, the 
MCNP5 (Monte Carlo N Particle) [264] software package was used to perform Monte 
Carlo simulations. MCNP is a general purpose Monte Carlo code designed to simulate 
the transport of photons, neutrons, and electrons.  
In our simulation cases, MCNP track length cell energy deposition tallies (F6 
tallies) were placed on the volumes of interest to detect the radiation doses and to obtain 
the corresponding energy deposited. The x-ray source was coded as a point source 
irradiating cone beam shaped x-rays uniformly onto the field and covering the whole 
simulation geometry, with the half beam angle of 8.05° and the edge beams tangent to the 
surface of the water sphere. One billion photons were used for each case, and the relative 
errors of the results were all smaller than 1%. 
All the simulations were performed on the Clemson Palmetto Cluster high-
performance computing system with over 1,800 nodes and 17,000 cores (as of November 
2013) [262]. The CPU time of each simulation was approximately 4 hours on a single 
node, with the total computation time of approximately 200 hours for executing one set 
of the simulation cases.  
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8.2.4   Monte Carlo Model Validation 
A simple case with corresponding analytical solutions was used in order to 
validate the Monte Carlo simulation results. Figure 8.2 shows the geometry of the 
validation cases utilized, which includes a cone-beam shaped mono-energetic x-ray 
source irradiating on a water sphere with a diameter ranging from 0.1 cm to 20 cm. 100 
million photons were used for a single simulation and all the relative errors for simulation 
results were smaller than 1%. For each simulation case, radiation dose to the water sphere 
(DW) was obtained from MCNP simulation results using F6 tallies, and the corresponding 
photon fluence (φ) incident on the water sphere was calculated.  
With the size of the water sphere reducing and the impact of scattering effect on 
absorbed doses can be negligible, as shown in Equation (8.3), the ratio of absorbed dose 
to photon fluence (DW/Φ) will approach the theoretical value of the mass absorption 
coefficient of water (μab/ρ) multiplied by the energy of the incident photons (hν) [285]. 
The mass absorption coefficients for analytical calculations were obtained from the 
National Institute of Standards and Technology (NIST) [286]. 
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Figure 8.2   Simulation geometry utilized for Monte Carlo validation. 
 
8.3   Results 
8.3.1   Monte Carlo Model Validation 
Figure 8.3 shows the validation results for the Monte Carlo validation simulations 
using the simulation geometry shown in Figure 8.2, as well as the analytical calculation 
results for different incident photon energies calculated using Equation (8.3). As shown 
in Figure 8.3, the value of DW/Φ at a specific photon energy level approaches the 
theoretical value as the size of the water sphere decreases. When the simulated water 
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sphere diameter is 0.1 cm, the difference between the simulation result and the analytical 
calculation of DW/Φ values was less than 0.1% for all the investigated incident photon 
energies (0.09% for 40 keV, 0.07% for 60 keV and 0.03% for 80 keV). These results 
showed the consistency and the reliability of the MCNP simulations using this type of 
simplified phantom. 
 
 
Figure 8.3   Dose to photon fluence ratios from MCNP validation simulations as well as 
analytical calculations as functions of the diameter of the simulated water sphere under 
different incident photon energies. 
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8.3.2   Energy Imparted and Relative Dose 
Table 8.2 shows values of relative energy imparted to iodine contrast containing 
spheres located at the center of the water phantom at 60 keV. The average dose to the 
contrast-containing sphere increases as the sphere radius decreases and as the iodine 
concentration increases. At the smallest sphere radius investigated (0.25 cm) and the 
highest iodine concentration (100 mg/ml), the absorbed radiation dose to this sphere was 
13 times higher than that with only water. These results may be contrasted with the 
values of relative energy imparted in the whole phantom which was not significantly 
affected (i.e., < 1%) at this smallest radius sphere and highest Iodine concentration. At 
the highest concentration (100 mg/ml) and contrast containing sphere (8 cm), the total 
energy imparted to the whole phantom merely increased by 11%.  
 
Table 8.2   Values of Erel(Iodine) and Erel(Phantom) for varying values of Iodine Sphere 
diameter and iodine concentration values under incident photon energy of 60 keV.  
Relative Energy 
Imparted 
I Concentration 
(mg/ml) 
Contrast Sphere Diameter (cm) 
0.5 4 16 
Erel(Iodine) 
1 1.14 1.14 1.11 
10 2.38 2.21 1.63 
100 13.0 5.80 2.18 
Erel(Phantom) 
1 1.00 1.00 1.01 
10 1.00 1.00 1.06 
100 1.00 1.00 1.11 
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Table 8.3 shows values of relative energy imparted to the spheres located at 
different points relative to the contrast sphere in the phantom under incident photon 
energy of 60 keV. The relative dose to the sphere in front is essentially unchanged, with a 
maximum dose reduction of 6%. The maximum dose reduction to the side sphere is 21%, 
but the dose reduction for the sphere located at the rear behind the contrast containing 
sphere is 89%, which reflects the marked increase in x-ray interaction in the contrast 
sphere at the largest radius and the highest iodine concentration. Even at an iodine 
concentration of 10 mg/ml, the dose at the rear location for the largest iodinated sphere is 
reduced by more than a factor of two.  
 
Table 8.3   Values of Erel(Front), Erel(Side), and Erel(Rear) for varying values of Iodine 
Sphere diameter and iodine concentration values under incident photon energy of 60 keV. 
Sphere Location 
I Concentration 
(mg/ml) 
Contrast Sphere Diameter (cm) 
0.5 4 16 
Erel(Front) 
1 1.00 1.00 1.00 
10 1.00 1.00 0.97 
100 1.00 0.99 0.94 
Erel(Side) 
1 1.00 1.00 0.98 
10 1.00 0.99 0.90 
100 1.00 0.95 0.79 
Erel(Rear) 
1 1.00 0.99 0.90 
10 1.00 0.93 0.41 
100 0.99 0.69 0.11 
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8.3.3   Relative Energy Imparted and Photon Energy  
Figure 8.4 shows values of Erel(Iodine) as a function of photon energy at the 
iodine concentration of 100 mg/ml. The three curves in Figure 8.4 show that the smallest 
contrast sphere diameter of 0.5 cm has the highest value of Erel(Iodine) of approximately 
13 at an incident photon energy of ~60 keV. The lowest values of Erel(Iodine) were 
generally at the lowest incident photon energy investigated of 35 keV. For the largest 
contrast sphere diameter of 16 cm, at 35 keV the value of Erel(Iodine) was 1.2.  
Figure 8.5 shows values of Erel(Side) and Erel(Rear) as a function of photon 
energy at the iodine concentration of 100 mg/ml. For the smallest contrast sphere 
diameter (0.5 cm), values of Erel(Side) and Erel(Rear) and approximately independent of 
photon energy and close to the value of unity. Erel(Side) has a minimum of 0.78 at 
approximately 75 keV for the largest contrast sphere diameter (16 cm). Values of 
Erel(Rear) are sharply influenced by the size of the contrast sphere diameter. At a contrast 
sphere diameter of 16 cm, however, values of Erel(Rear) monotonically increase from a 
low of 0.09 at 35 keV to ~0.36 at 150 keV.  
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Figure 8.4   Values of Erel(Iodine) for different sized Iodine Sphere (d = 0.5, 4, 16 cm) as 
functions of the incident photon energy under the iodine concentration of 100 mg/ml.  
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Figure 8.5   Values of (A) Erel(Rear) and (B) Erel(Side) for different sized Iodine Sphere 
(d = 0.5, 4, 16 cm) as functions of the incident photon energy with iodine concentration 
of 100 mg/ml.    
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Figure 8.6 shows how Erel(Phantom) varies with incident photon energies. For the 
two smallest contrast sphere diameter values (0.5 cm and 4 cm), this parameter is 
relatively close to unity, and independent of the incident photon energy. At the contrast 
sphere diameter value of 16 cm, however, the value of Erel(phantom) shows a strong 
photon energy dependence and shows a maximum value of 1.2 at incident photon energy 
of 100 keV. It is also notable that highest values of Erel(phantom) in Figure 8.6  are 
generally an order of magnitude lower than the corresponding highest values of 
Erel(Iodine) shown in Figure 8.4. In addition, the maximum values of Erel(phantom) in 
Figure 8.6 are for the largest contrast sphere diameter (16 cm) whereas the maximum 
values of Erel(Iodine) in Figure 8.4 are for the smallest contrast sphere diameter (0.5 cm).  
 
Figure 8.6   Values of Erel(Phantom) for different sized Iodine Sphere (d = 0.5, 4, 16 cm) 
as functions of the incident photon energy with iodine concentration of 100 mg/ml.  
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8.4   Discussion 
In this study we investigated the grounds for the rising concerns of the radiation 
dose increase caused by the administration of iodinated contrast agents during diagnostic 
radiological imaging. As a general conclusion, the data presented in Tables 8.1 and 8.2 
clearly showed that, although the utilization of iodine can increase the localized absorbed 
radiation dose, it is primarily a result of the redistribution of the energy deposited in the 
phantom. Our results also demonstrated that the increase in the total amount of energy 
deposited is relative modest, and for most practical purposes is likely to be of only 
marginal importance.  
The Monte Carlo algorithm is by far the best and most practical tool for radiation 
dosimetry studies without cumbersome radiation dose measurements. The computational 
time cost of the Monte Carlo simulations has been decreasing with the development of 
computer technology, such as multi-core CPU and computational clusters. Nonetheless, 
the accuracy of Monte Carlo simulations not only depends on the number of particle 
transport events simulated, but also relies on the design of the irradiation geometry as 
well as the normalization method used for processing the results. MCNP is a validated 
Monte Carlo-based platform which suits our purpose of investigating the energy 
distribution on the basis of relative values, but in order to use the corresponding absolute 
values, further normalization and validation will be required.  
The results of Erel(Iodine) show that there could be substantial radiation dose 
increase within small volumes of interest under a high iodine concentration, i.e., local 
dose increased 13 times to 100 mg/ml iodinated solution when compared with that to the 
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same volume of water (r = 0.5 cm). This significant dose increase is caused by the less 
diluted solution and the short attenuation depth along the x-ray. In clinical practice, 
however, the 100 mg/ml iodine concentration is unlikely reached at the targeted tissue 
during x-ray imaging. The contrast agent with an original 300 to 400 mg/ml Iodine 
concentration injected into the patient would be diluted by blood and extracellular liquids 
and reach various iodine concentrations at different tissues depending on the phase when 
the contrast enhanced imaging is taken and the iodine uptake of a specific tissue. 
Increase in HU values caused by the application of iodinated contrast to patients 
during multislice CT scans can be used as an indication of the concentration of the local 
iodinated contrast agent. Table 8.4 lists the mean HU enhancement according to recent 
literature [278, 287]. For an arterial phase scan, the increase in HU values ranged from 
~10 for the liver to 177 for the kidney and 375 for the aorta. For a venous phase scan, the 
increase in HU values ranged from ~41 for the pancreas to ~165 for the kidney. These 
increased values are affected by the type and amount of contrast agent administered, the 
concentration of iodine in the contrast agent, the irradiation parameters, as well as the 
phase of which the image is taken. Compared with the HU values of different iodine 
concentrations investigated in this paper, shown in Table 8.1, the iodine concentration in 
most organs/tissues during imaging is in between 1 to 10 mg/ml under the assumption 
that a patient can be simplified as a water phantom.  
The change of the relative total energy imparted onto the patient during an 
examination, represented by Erel(Phantom), was small even under the extreme iodine 
concentration of 100 mg/ml. The largest increase in the relative total energy imparted was 
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21% for a contrast sphere with diameter of 16 cm at 100 keV, which means for the largest 
solid organ in human body, i.e. the liver, the utilization of iodinated contrast agent during 
contrast-enhanced imaging process will cause a less than 21% increase in the total energy 
absorbed under any technical parameter setting. For the other two sizes of VOI (4 cm and 
0.5 cm) investigated, the Erel(Phantom) value increase was within 1% under the three 
iodine concentrations and six incident photon energy levels. 
 
Table 8.4   Mean HU value difference between after and before the injection of iodinated 
contrast agent in different tissues during multislice CT at 120 kV from literatures. 
Organs/ 
Tissues 
(2010) E Amato et al. (2004) S Fenchel et al. 
Iodine concentration  
= 300 mg/ml 
Iodine concentration  
= 300 mg/ml 
Iodine concentration 
 = 400 mg/ml 
Venous Phase 
Arterial 
Phase 
Venous 
Phase 
Arterial 
Phase 
Venous 
Phase 
Aorta N/A 260 108 375 112 
Liver 58.9 10 52 12 59 
Kidney 146 128 149 177 165 
Pancreas 41.1 40 57 59 79 
Spleen 76.0 41 70 68 69 
Thyroid 102 N/A N/A N/A N/A 
 
We also investigated the change of the energy distribution pattern caused by the 
application of iodinated contrast agents. With little increase of the total energy imparted 
on the phantom and the remarkable increase of local deposited energy caused by the 
iodine solution, the energy absorption in the adjacent volumes surrounding the volume of 
interest (VOI) decreases. Under the extreme iodine concentration of 100 mg/ml, the 
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change in energy deposited in front of the VOI, Erel(Front), was trivial and less than 9%. 
The larger the VOI is, the smaller the value of Erel(Front) is, which is caused by the less 
penetrated photons and thus fewer large-angle backscatter. With all the parameter settings 
considered, the decrease in energy absorption was up to 91% for the investigated volume 
behind the VOI along the x-ray beam and within 10% for the investigated volume to the 
side of the VOI.  
As the main factor determining the total output energy from the x-ray source, 
incident photon energy affects the increase of the local absorbed dose as well as the total 
energy imparted caused by iodinated contrast agents. According to our results, under 
iodine concentration of 100 mg/ml, the value of Erel(Iodine) reached peak at ~60 keV for 
contrast sphere diameter of 0.5 cm, ~75 keV for contrast sphere size of 4 cm, and ~100 
keV for contrast sphere size of 16 cm, as a result of the balance between the penetration 
and the absorption of the x-rays. As is similar for the trends of Erel(Iodine) values, the 
value of Erel(Phantom) reached a plateau at ~100 keV for a 16 cm diameter contrast 
sphere under 100 mg/ml iodine concentration. Our results suggested that for a typical 
radiographic imaging with mean beam energy of 35-40 keV, the maximum local dose 
increase caused by contrast agent would be ~10 times, and the maximum total energy 
imparted increase would be less than 3%. In comparison, for a typical chest CT 
examination with mean beam energy of ~ 60 keV, the local dose increase caused by 
contrast agent for a small object could reach ~13 times, while the maximum total energy 
imparted increase caused by the contrast agent is ~11%.  
It should be pointed out explicitly that in order to further predict the increased 
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effective dose and carcinogenic risks caused by the injection of iodinated contrast agent 
based on the results of this study, radiobiological and micro-dosimetry studies must be 
performed. For a patient body undergoing the contrast-enhanced imaging, the energy 
distributed may not be where the radio-sensitive tissues are. We studied the energy 
absorption patterns assuming the tissue was context-free and the iodine solution was 
evenly distributed within the volume of interest. In practical clinical and radiobiological 
considerations, the convection and diffusion of the contrast agent in the human body is 
much more complicated, considering factors such as the structural differences of each 
organ/tissue, the balance between the blood and extracellular matrix fluids, and the 
observation time frame, etc. 
 
8.5   Conclusion 
In conclusion, it was shown based on this study that by administrating the 
iodinated contrast, the localized radiation dose could increase by up to 1300%, whereas 
the total energy imparted increase by merely 11%. The additional total energy absorbed 
due to the presence of iodinated contrast agent was relatively small compared with the 
corresponding local dose absorption increase. Our results suggested that concerns 
regarding the increased patient doses in diagnostic radiological examinations due to 
higher x-ray absorption by iodinated contrast medium may be unjustified depending on 
the volume of interest and irradiation parameters. Utilization of iodine contrast agent 
primarily changes the pattern of energy deposition in the irradiated region, rather than 
increasing the patient doses. As for the potential additional radiation-induced 
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carcinogenic risks caused by the iodinated contrast agent, further investigation needs to 
be performed with radiobiology expertise.   
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CHAPTER 9   OVERALL CONCLUSIONS AND FUTURE DIRECTIONS 
9.1   Conclusions 
In the US, radiation doses from medical imaging resulted in an increase of ~600% 
in a single generation [1]. Among medical exposures to patients, computed tomography 
(CT) composes 49% of the collective doses, and interventional fluoroscopy composes 
14%. Radiation exposure to patients undergoing diagnostic radiological procedures 
causes increased lifetime carcinogenic risks, especially for pediatric patients who are 
more radiosensitive than adults. The correlation between procedural x-ray techniques and 
the radiation doses to patients, as well as the resultant image quality, is not well 
understood, and therefore the focus of the performed studies. 
The major focus of this work is the investigation of the effect of irradiation 
technical parameters on radiation doses to patients, and its major impact is the potential 
in optimizing radiation doses to patients undergoing diagnostic radiological examinations, 
such as CT scans and interventional radiology procedures. This information will be 
useful in better understanding the causes of the unnecessary medical radiation doses and 
will help reach the goal of the as low as reasonable achievable (ALARA) rule for medical 
radiation dosimetry. Our studies underlined the impact of projection angles, x-ray tube 
current modulation and scan regions on the resultant patient doses (Aim 1), and also 
analyzed the cancer risks to adults undergoing CT scans with the most important 
radiosensitive organs causing the carcinogenic risk increase (Aim 2). Furthermore, the 
Monte Carlo model built for our studies for the patient doses during the pediatric 
interventional radiology examinations combined image quality into the input photon 
179 
 
energy – radiation dose relationship, and thus achieved the goal of maintaining image 
quality while reducing patient doses in the quantitative perspective (Aims 3 and 4). These 
studies will also build the baseline for image quality related dose optimization for 
different types of diagnostic radiological procedures and different patient populations. 
The Monte Carlo model developed will not only facilitate the current understanding of 
patient dose optimization in diagnostic radiology, but will also offer the clinical field a 
realistic method for estimating radiation doses to radiology staff during diagnostic and 
interventional radiology examinations.  
 
Chapter 3 (addressing Aim 1): In this study, absorbed doses to patients 
undergoing cone beam CT scans as functions of the x-ray tube projection angle were 
calculated using a Monte Carlo software package (PCXMC). Average absorbed doses 
were generated and recorded for five radiosensitive organs (i.e., breast, colon, lung, red 
bone marrow, and stomach), as well as the corresponding effective dose. Doses for both 
CT gantries were obtained every 15 of the x-ray tube projection angle, at each of six 
locations in 10 cm increments along the patient long axis. Our results showed that there 
were major differences in organ and effective dose as the x-ray tube rotates around the 
patient, which further suggested that the use of x-ray tube current modulation could 
produce substantial reductions in organ and effective dose for body imaging with cone 
beam CT.  
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Chapter 4 (addressing Aim 1): In this study, we investigated how patient 
effective doses vary as a function of x-ray tube projection angle, as well as patient long 
axis, and quantified how x-ray tube current modulation affects patient doses in chest CT 
examinations. Our results showed that the effective dose maxima occur for AP 
projections at the location of the (radiosensitive) breasts. It was concluded that the 
existing x-ray tube current modulation schemes are expected to reduce patient effective 
doses in chest CT examinations by about 10%, with longitudinal modulation accounting 
for two thirds and angular modulation for the remaining one third.  
 
Chapter 5 (addressing Aim 1): The choice of the scanned region could also 
affect organ doses in CT. In this study, we used Monte Carlo algorithm based ImPACT 
CT Patient Dosimetry Calculator (version 1.0) to compute absorbed doses to eight 
radiosensitive organs of interest in medical radiation dosimetry. The ratios of the dose to 
an organ at a specified scan length to the maximum organ dose resulted from a uniform 
whole body irradiation were calculated as functions of increasing scan length. 
Furthermore, the impact of different scan directions on dose to the same organ was 
investigated. Our results showed that for each organ, the ratio of organ dose at a set scan 
length to the maximum organ dose was independent of type of scanner, and increased 
monotonically to unity with increasing scan length. CT scans limited to direct irradiation 
of an organ result in absorbed doses that range from 70% of that from the uniform whole 
body irradiation for small organs to 85% of that from the uniform whole body irradiation 
for large organs.  
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Chapter 6 (addressing Aim 2): In this study, the resultant cancer risks from the 
amount of radiation used to perform body CT examination were estimated. The ImPACT 
CT Patient Dosimetry Calculator was used to compute values of organ doses for adult 
body CT examinations. Results are presented for cancer risks per unit DLP and unit 
effective dose for 11 sensitive organs, as well as estimates of the contribution from ―other 
organs.‖ For patients who differ from a standard-sized adult, correction factors based on 
the patient weight and antero-posterior dimension are provided to adjust organ doses and 
the corresponding risks. Our results showed that at constant incident radiation intensity, 
for CT examinations that include the chest, risks in females are markedly higher than 
those for males, whereas for examinations that include the pelvis, risks in males were 
slightly higher than those in females. In abdominal CT scans, risks for males and female 
patients are very similar. For abdominal CT scans, increasing the patient age from 20 to 
80 resulted in a reduction in patient risks of nearly a factor of five. It was concluded that 
cancer risks in body CT can be estimated from the examination Dose Length Product by 
accounting for sex, age, as well as patient physical characteristics. 
 
Chapter 7 (addressing Aims 3 and 4): The purpose of this study was to 
investigate the role of x-ray photon energy in determining skin dose, energy imparted and 
image quality in pediatric interventional radiology using a Monte Carlo model built on 
MCNP5 platform. Contrast, relative noise, and contrast-to-noise ratio (CNR) were 
obtained for imaging under two scenarios: 1) without grids at different incident photon 
energies; and 2) with 8:1 grids (10% scatter, 70% primary beam transmission). Our 
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results showed that under a fixed image quality represented by CNR, energy imparted 
increased with photon energy, while skin dose was not a monotonic function of photon 
energy and reached its minimum at ~ 40 keV. While under fixed output energy fluence, 
both skin dose and energy imparted decrease monotonically with the incident photon 
energy, and the skin dose is more sensitive to changes in photon energy than total energy 
imparted. These results demonstrated that using Monte Carlo methods, the optimized x-
ray tube voltage for a relatively low dose under the desired image quality could be 
obtained for a specific patient undergoing a certain type of diagnostic examination. 
 
Chapter 8 (side project of Aims 3 and 4): In this study, we investigated the 
changes in the pattern of energy deposition in tissue-equivalent phantoms following the 
introduction of iodinated contrast media using a Monte Carlo model built using MCNP5 
codes. Relative values of energy imparted to the iodine contrast, as well as to the whole 
phantom, were calculated. Changes in patterns of energy deposition around the iodine 
contrast-filled volume were also investigated. Our results indicated that adding iodine can 
result in values of localized absorbed dose increasing by more than an order of magnitude, 
but the total energy deposition is generally very modest (i.e., <10%). Furthermore, our 
results showed that adding iodine primarily changes the pattern of energy deposition in 
the irradiated region, rather than increasing the corresponding patient doses. 
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9.2   Challenges 
9.2.1   Clinical Application 
The results obtained from Chapter 3 to Chapter 6 are clinically practical, but there 
are limitations that should be noted. For example, it is important to note that the 
methodology developed in this study for CT scans was based on adult patients and cannot 
be extrapolated to children [38, 222]. Children cannot simply be assumed to be small 
adults, because the relative proportions of different organs and tissues change with age. 
[248] In order to obtain the conversion factors for children, the model has to be altered to 
fit pediatric patients, and also the risk factors need to be recalculated. 
 
9.2.2   Software Limitations 
Based on patient dose optimization studies in Chapters 3-6 (Aim 1 and Aim 2), 
the limitations of the current dosimetry software were exposed. For example, the existing 
software packages do not permit image quality to be quantified, because neither the 
distribution of scattered photons nor the scatter-to-primary ratio on the imaging plane is 
available in their output. In order to take image quality into consideration when 
optimizing patient doses, our own in-house model needs to be built (Aim 3 and Aim 4).  
 
9.2.3   Computational Time 
For computations done with commercially available software in Chapters 3 to 6, 
the computations were performed on a single PC because of the software requirements 
(by PCXMC and ImPACT CT). It was not possible to shorten the computational time 
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used for these calculations. Meanwhile, the computational time for each simulation case 
was relatively short because the software used pre-stored Monte Carlo calculation results. 
However, for simulations performed using our in-house models on MCNP5 
platform, the Monte Carlo simulations were highly CPU-time consuming because of its 
property of real-time particle transport calculations. It could take weeks to complete all 
the simulations needed for each batch of the experiment. In order to shorten the 
simulation time, we utilized the multi-threaded capabilities of the MCNP software under 
Linux system environment on the Clemson Palmetto Cluster.  
 
9.2.4   Data Processing 
The data file from each simulation generated in Chapter 8 and Chapter 9 may be 
close to a hundred of megabytes, with massive results for each mesh location on the 
imaging plane. This magnitude of data may be too large to be viewed using Microsoft 
notepad, or processed by the common data management software such as Microsoft 
Excel. To solve this problem, the data were viewed and extracted using large text data 
processing software such as Ultraedit, and will be stored and accessed using a relational 
database and then connected with Microsoft Access with a user inquiry interface. 
 
9.3    Future Goals 
The goal of this project was to gain a better understanding of the roles of different 
radiological imaging technique factors on the patient doses in diagnostic radiological 
procedures. By investigating the impact of different parameters in CT scans on doses and 
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cancer risks to adult patients using commercially available Monte Carlo software, we 
looked into the possible optimization of technical parameters for CT examinations to 
achieve lower patient doses. Based on these studies, the limitations of the current Monte 
Carlo software were analyzed and our own Monte Carlo model was proposed for 
simulations of patient doses during pediatric interventional radiology procedures. The 
ultimate goal of this study is to develop a comprehensive dosimetry database using 
Monte Carlo technique, with the output of patient doses, operator doses, and the 
corresponding radiation-induced carcinogenesis risks for pediatric interventional 
radiology procedures.  
 
Chapter 3, 4 & 5: We hope to further study the impact of the irradiation technical 
factors (projection angle, scan length, etc.) on organ doses and effective dose to pediatric 
patients during different types of CT scans. Future work can be done to investigate the 
specific pediatric procedures and compare among pediatric patients with different ages.  
 
Chapter 6: We hope to further study the radiation-induced carcinogenic risks to 
adult patients based on risk databases for different populations, such as American, Asian, 
and European populations. Current existing cancer risk databases from ICRP 103, Health 
Physics Association (HPA) and BEIR VII are all targeted on different population 
compositions. Radiation risks calculated using different radiation risk databases can be 
used upon more specific targeted populations and have more specific clinical indications. 
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Chapter 7: 1) Further studies could be done to improve the simulation phantoms.  
The average thickness of the human skin is 0.2~0.3 cm. For the next step, we hope to 
research references about skin dose simulation, and also examine which skin layer should 
be accounted for (thin skin or thick skin). Finally, the size of the water phantom can be 
varied to represent different patient age groups. 
2) Additional studies may be carried out with the goal of decreasing the 
computational cost and increasing the simulation result accuracy. The results from 
simulations using one million photons are suitable for our pilot studies, but not 
sufficiently rigorous for future publishing. In the next step, we need to use a larger 
number for simulation histories (simulated source particles), and at the same time 
improve the mesh tally design to decrease the computation time for each run. We also 
hope to use parallel programming instead of multi-thread programming to shorten the 
computational time. 
3) Also of interest are the studies in which we vary the transmission rates of 
primary and scattered photons of the grids with the incident photon energy. The 
feasibility of simulating different transmission rates should be investigated. Also, 
studying the influence of different types of grids could also be of interest.  
 
Chapter 8:  We hope to further investigate the potential additional radiation-
induced carcinogenic risks caused by the iodinated contrast agent based on radiobiology 
expertise. The deposition of the iodinated contrast agent varies because of the different 
uptake rates of organs and tissues. We have investigated the increased radiation dose and 
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energy imparted caused by the contrast agent based on the assumption that the iodine 
concentration is uniform and not affected by the type of tissue/organ. In order to further 
estimate the cancer risks caused by the contrast agent during irradiation, the deposition of 
iodine and the radio-sensitivity of the contrast-absorbed organs needs to be considered.  
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